People_

Professor Rachael Morton

Professor
Deputy Director, NHMRC Clinical Trials Centre
Director, Health Economics &
Health Technology Assessment

Phone

+61 2 9562 5013

Fax

+61 2 9562 5387

rachael.morton@sydney.edu.au

Websites

Related website - ACTA

Biographical details

Rachael Morton is Professor and Director of health economics and health technology assessment at the NHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney. She specialises in trial-based and modelled economic evaluation, and elicitation of patient preferences using discrete choice experiments. Her research incorporates patient-centred and economic outcomes into clinical trials of diagnostic tests, new treatments and models of care to facilitate policy decision-making on the basis of cost-effectiveness.

Research interests

Professor Morton’s research interests include the health economics of melanoma, and chronic kidney disease. She also has an interest in health equity in disadvantaged populations both in Australia and overseas. Her methodological interests include systematic reviews of economic evidence, assessment of test evaluation and monitoring, measurement of quality of life and wellbeing, and end-of-life care.

Teaching and supervision

Prof Morton coordinates short courses in health economics for government and industry and currently supervises 7 PhD candidates.

Current projects

Professor Morton’s current melanoma projects include:

the cost-effectiveness of whole brain radiotherapy for brain metastases; the cost-effectiveness of pelvic lymph node surgery; the benefits and harms of CT and PET/CT surveillance in stage III melanoma; the cost-effectiveness of specialized surveillance in individuals at high risk of melanoma; the cost-effectiveness of presenting genomic risk information, and the safety and efficacy of high-dose Vitamin D to prevent melanoma recurrence. Many of these trials have been made possible through her longstanding collaboration with the Australia and New Zealand Melanoma Trials Group (ANZMTG), and the Melanoma Institute Australia.

Professor Morton’s current kidney projects include the cost-effectiveness of coronary artery disease screening in wait-listed recipients (CARSK trial); the impact of social determinants on kidney disease outcomes using data from the Study of Heart and Renal Protection (SHARP); a Cochrane review of interventions to aid employment for people on dialysis; and the evaluation of an advance care planning intervention for older patients managed with dialysis. Analysis of the SHARP trial data is a result of her overseas NHMRC fellowship and collaboration with the Health Economics Research Centre at the University of Oxford, UK in 2013-2015; as well as ongoing links with King’s College London.

The above studies are being undertaken with a range of collaborators at Sydney University, the Melanoma Institute Australia, the University of Ottawa & University of British Columbia, [Canada] and the University of Bristol, King’s College London & University of Oxford, [UK].

Associations

-Past President, Health Services Research Association of Australia and New Zealand (HSRAANZ)

-Guest discussant, Economics Sub Committee of Pharmaceutical Benefits Advisory Committee, 2013, 2015, 2016

-Executive member, Dialysis Advisory Committee, Australia and New Zealand Society of Nephrology (ANZSN)

-Expert reference group – Joanna Briggs Institute

-Member, Cochrane Equity Methods Group

-Member, International Health Economics Association

Awards and honours

2019 - Supervisor of the Year (SUPRA), Sydney Medical School

2019 - Faculty Member & Honorary Investigator, Melanoma Institute Australia

2015 - Helen Triantyfallou Conference award, (Top ranked applicant) Sydney Medical School, University of Sydney

2010 - Dean’s prize for Student Research publications, Commendation, Sydney Medical School, University of Sydney

Themes

Obesity, Diabetes and Cardiovascular Disease, Cancer, Healthy Ageing

Keywords

Epidemiology, Health economics, Health policy, Health services and management, Patient reported outcome measures

Approaches

Assessment/Evaluation, Clinical Trials, Economics

International links

Canada	(Bruyere Institute, University of Ottawa ) Since 2013 I have been working with the Cochrane Equity [and Economics] Methods groups to look at ways of combining evidence into systematic reviews using the GRADE methodology
Canada	(Vancouver hospital, University of British Columbia) I am collaborating with nephrologists, health economists and biostatisticians to examine multi-country cost-effectiveness of screening kidney transplant recipients for heart disease.
United Kingdom	(Cicely Saunders Institute, King¿s College London ) Since 2012 I have worked with palliative care physicians to assess resource use, costs and quality of life in end-of-life care for people with kidney disease.
United Kingdom	(Health Economics Research Centre, University of Oxford) Since 2012 I have been part of a multi-disciplinary team of health economists, epidemiologists and clinicians to assess the impact of social determinants of health (such as educational attainment and household income) on cardiovascular and kidney outcomes.
United States	(Johns Hopkins University) Patient Reported Outcome Measures (PROMs) partnership grant with Prof Claire Snyder to investigate better ways of implementing and interpreting PROMs in chronic conditions.

PhD and master's project opportunities

Patient preferences and willingness to pay for genomic information in cancer and cardiovascular disease

Current research students

Project title	Research student
The role of routinely collected administrative data for healthcare resource use measurement in clinical trials and economic evaluations	Salma FAHRIDIN
Discrete choice experiments (DCEs) to assess patient and clinician preferences for artificial intelligence (AI)-driven skin cancer diagnosis	Lorelie FLOOD
Out of hospital cardiac arrest patients: A costing study	Kyumin JANG
The FLIRT Trial: A phase III international multi-centre double-blind randomised controlled trial to evaluate the effectiveness of fluoroquinolone-based therapy versus placebo for isoniazid-resistant tuberculosis.	Yuling KE
Incorporating environmental impacts into health technology assessments	Jake WILLIAMS

Publications

By Type

Expand all

Book Chapters

Morton, R., Webster, A. (2014). Quality of Life in Chronic Kidney Disease. In Mustafa Arici (Eds.), Management of Chronic Kidney Disease, (pp. 487-499). Berlin: Springer-Verlag. [More Information]

Journals

Nikolovski, J., Kim, B., Morton, R., Mercieca-Bebber, R., Levesque, J., Tinsley, M., Sutherland, K., Rossiter, B., Fagan, M., Hartas, G., Rutherford, C. (2025). Strategies to promote the completion of patient-reported outcome measures by culturally and linguistically diverse and Indigenous Peoples in clinical care settings: A systematic review. Quality of Life Research. [More Information]
Hole, B., Coast, J., Caskey, F., Selman, L., Rooshenas, L., Kimpton, G., Snead, C., Field, A., Morton, R. (2024). A choice experiment of older patients’ preferences for kidney failure treatments. Kidney International. [More Information]
Burns, B., Marschner, I., Eggins, R., Buscher, H., Morton, R., Bendall, J., Keech, A., Dennis, M. (2024). A randomized trial of expedited intra-arrest transfer versus more extended on-scene resuscitation for refractory out of hospital cardiac arrest: Rationale and design of the EVIDENCE trial. American Heart Journal, 267, 22-32. [More Information]
Nikolovski, J., Morton, R., Mercieca-Bebber, R., Armstrong, M., Hartas, G., Rossiter, B., Fagan, M., Tinsley, M., Snyder, C., Aiyegbusi, O., Rutherford, C., et al (2024). Acceptability and timing considerations when administering patient-reported outcome measures (PROMs) among people with chronic health conditions who are culturally and linguistically diverse (CALD): a qualitative study protocol. BMJ Open, 14(9), e083346. [More Information]
Mersiades, T., Solomon, B., Thomas, D., Lee, C., Parry, M., Sebastian, L., Ballinger, M., Collignon, E., Turnbull, O., Yip, S., Morton, R., Brown, C., Itchins, M., Simes, R., Pavlakis, N., et al (2024). ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue. Future Oncology, 20(7), 361-371. [More Information]
Shah, K., Hedley, J., Robledo, K., Wyld, M., Webster, A., Morton, R. (2024). Cost-effectiveness of Accepting Kidneys from Deceased Donors with Common Cancers - A Modeling Study. Transplantation, 108(8), e187-e197. [More Information]
Siriwardana, A., Hoffman, A., Morton, R., Smyth, B., Brown, M. (2024). Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients. Value in Health, 27(4), 469-477. [More Information]
Yi, T., O'Hara, D., Smyth, B., Jardine, M., Levin, A., Morton, R. (2024). Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research. Canadian journal of kidney health and disease, 11. [More Information]
Desson, Z., Figtree, G., Webster, J., Jennings, G., Redfern, J., Nicholls, S., McNamara, M., Deeming, S., Doyle, K., Ramanathan, S., Morton, R., et al (2024). Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study. Journal of Human Hypertension, 38(2), 177-186. [More Information]
De La Mata, N., Khou, V., Hedley, J., Kelly, P., Morton, R., Webster, A., Wyburn, K. (2024). Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist. Nephrology Dialysis Transplantation, 39(7), 1138-1149. [More Information]
Williams, J., Bell, K., Morton, R., Dieng, M. (2024). Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review. Value in Health, 27(6), 794-804. [More Information]
Martin, A., Cust, A., Lo, S., Morton, R., Kasparian, N., Collgros Totosaus, H., Teh, N., Martin, L., Guitera, P. (2024). Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single-arm, feasibility study of a clinical intervention at two tertiary centres (MOBILEMEL). Journal of the European Academy of Dermatology and Venereology. [More Information]
Ni, Y., Watts, C., Scolyer, R., Madronio, C., Armstrong, B., Morton, R., Menzies, S., Mann, G., Thompson, J., Cust, A., Lo, S. (2024). Prognosis for people with multiple primary melanomas compared with a single primary melanoma. Journal Of The American Academy Of Dermatology, 90(1), 170-174. [More Information]
Jeyaprakash, P., Loh, H., Boyle, A., Ford, T., Porter, T., Negishi, K., Pathan, F., Ozawa, K., Robledo, K., Shah, K., Morton, R., Yu, C., Madronio, C., Hallani, H. (2024). Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial. American Heart Journal, 275, 163-172. [More Information]
Douglas, C., Alexeev, S., Middleton, S., Gardner, G., Kelly, P., McInnes, E., Rihari-Thomas, J., Windsor, C., Morton, R. (2024). Transforming nursing assessment in acute hospitals: A cluster randomised controlled trial of an evidence-based nursing core assessment (the ENCORE trial). International Journal of Nursing Studies, 151, 104690. [More Information]
Wei, Z., Gilbert, Y., Thananjeyan, A., Cope, J., Morton, R., Li, A., Pham, C., Ward, M., Oei, J. (2023). A Systematic Review of Clinical Practice Guidelines for Neonatal Abstinence Syndrome. Children, 10(10). [More Information]
Shah, K., Wyld, M., Hedley, J., Waller, K., De La Mata, N., Webster, A., Morton, R. (2023). Cost-effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-borne Virus Infection Transmission. Transplantation, 107(9), 2028-2042. [More Information]
Taylor, W., Tuffaha, H., Hawley, C., Peyton, P., Higgins, A., Scuffham, P., Nemeh, F., Balagurunathan, A., Hansen, P., Jacques, A., Morton, R. (2023). Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals. PloS One, 18(2023-12-12 00:00:00). [More Information]
Agarwal, N., Shah, K., Dansie, K., Bennett, P., Greenham, L., Brown, C., Smyth, B., McDonald, S., Jesudason, S., Viecelli, A., Morton, R. (2023). Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial. BMC Nephrology, 24(1). [More Information]
Callander, E., Tarnow-Mordi, W., Morton, R., Mol, B., Kumar, S. (2023). Intrapartum use of sildenafil citrate to prevent fetal compromise and emergency operative birth in term pregnancies in the United Kingdom and Australia: A preliminary cost-effectiveness analysis. International Journal of Gynecology & Obstetrics. [More Information]
Law, C., Cust, A., Smit, A., Trevena, L., Fernandez Penas, P., Nieweg, O., Menzies, A., Wordsworth, S., Morton, R. (2023). Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine, 25(12), 100970. [More Information]
Mehrotra, R., Davison, S., Farrington, K., Flythe, J., Foo, M., Madero, M., Morton, R., Tsukamoto, Y., Unruh, M., Cheung, M., et al (2023). Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 104(3), 441-454. [More Information]
Livingstone (nee Ratcliffe), A., Howard, K., Menzies, A., Long, G., Stockler, M., Morton, R. (2023). Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma - A Discrete Choice Experiment. The Patient, 16(5), 497-513. [More Information]
Blake, S., Guitera, P., Cust, A., Galea, C., Lo, S., Scolyer, R., Armstrong, B., Thompson, J., Menzies, S., Madronio, C., Morton, R., Mann, G., Watts, C. (2023). The association of dermatologist demographic density with melanoma survival in New South Wales, Australia. Australasian Journal of Dermatology, 64(3), 425-429. [More Information]
Law, C., Stevenson, A., Solomon, M., Hague, W., Simes, R., Morton, R. (2022). ASO Author Reflections: Is laparoscopic-Assisted Surgery More Costly than Traditional Open Resection for Rectal Cancer Treatment? Annals of Surgical Oncology, 29(3), 1935-1936. [More Information]
Mahumud, R., Janda, M., Soyer, H., Fernandez Penas, P., Mar, V., Morton, R. (2022). Assessing the value of precision medicine health technologies to detect and manage melanoma. Medical Journal of Australia, 217(6), 275-278. [More Information]
Nagarajan, S., Lewis, V., Halcomb, E., Rhee, J., Morton, R., Mitchell, G., Tieman, J., Phillips, J., Detering, K., Gavin, J., Clayton, J. (2022). Barriers and facilitators to nurse-led advance care planning and palliative care practice change in primary healthcare: a qualitative study. Australian Journal of Primary Health, 28(2), 151-157. [More Information]
Siu, H., Carey, S., Jones, L., Morton, R., Koh, C. (2022). Detailed analysis of in-hospital costs for adult patients with type III intestinal failure: A single-center study with global implications. Journal of Parenteral and Enteral Nutrition, 46(3), 685-692. [More Information]
Jobson, D., Roffey, B., Best, R., Button-Sloan, A., Cossio, D., Evans, S., Shang, C., Moore, J., Arnold, C., Mann, G., Morton, R., et al (2022). Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper. BMJ Open, 12(9). [More Information]
Mitchell, P., Morton, R., Hiligsmann, M., Husbands, S., Coast, J. (2022). Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands. The European Journal of Health Economics. [More Information]
Cohen, P., Webb, P., King, M., Obermair, A., Gebski, V., Butow, P., Morton, R., Lawson, W., Yates, P., Campbell, R., Brand, A., et al (2022). Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer. International Journal of Gynecological Cancer, 32(4), 560-565. [More Information]
Law, C., Stevenson, A., Solomon, M., Hague, W., Wilson, K., Simes, R., Morton, R. (2022). Healthcare Costs of Laparoscopic versus Open Surgery for Rectal Cancer Patients in the First 12 Months: A Secondary Endpoint Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT). Annals of Surgical Oncology, 29(3), 1923-1934. [More Information]
Greenham, L., Bennett, P., Dansie, K., Mister, R., Smyth, B., Westall, P., Herzog, S., Brown, C., Simes, R., Morton, R., et al (2022). The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis. Trials, 23(1), 419. [More Information]
Dempsey, K., Ferguson, C., Walczak, A., Middleton, S., Levi, C., Morton, R. (2022). Which strategies support the effective use of clinical practice guidelines and clinical quality registry data to inform health service delivery? A systematic review. Systematic Reviews, 11(1). [More Information]
de Jong, Y., van der Willik, E., Milders, J., Voorend, C., Morton, R., Dekker, F., Meuleman, Y., van Diepen, M. (2021). A meta-review demonstrates improved reporting quality of qualitative reviews following the publication of COREQ- and ENTREQ-checklists, regardless of modest uptake. BMC Medical Research Methodology, 21(1), 184. [More Information]
Dieng, M., Morton, R. (2021). ASO Author Reflections: Longitudinal Diagnostic Accuracy of Surveillance Imaging in Resected Stage III Melanoma Patients. Annals of Surgical Oncology, 28(8), 4570-4571. [More Information]
Watts, C., McLoughlin, K., Goumas, C., Van Kemenade, C., Aitken, J., Soyer, H., Fernandez Penas, P., Guitera, P., Scolyer, R., Morton, R., Menzies, S., Caruana, M., Kang, Y., Mann, G., Madronio, C., Armstrong, B., Thompson, J., Cust, A., et al (2021). Association between Melanoma Detected during Routine Skin Checks and Mortality. JAMA Dermatology, 157(12), 1425-1436. [More Information]
Mahumud, R., Sahle, B., Owusu-Addo, E., Chen, W., Morton, R., Renzaho, A. (2021). Association of dietary intake, physical activity, and sedentary behaviours with overweight and obesity among 282,213 adolescents in 89 low and middle income to high-income countries. International Journal of Obesity, 45(11), 2404-2418. [More Information]
Khou, V., De La Mata, N., Morton, R., Kelly, P., Webster, A. (2021). Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand. Nephrology Dialysis Transplantation, 36(8), 1527-1537. [More Information]
Owen, K., Ibiebele, I., Simpson, J., Morton, R., Morris, J., Torvaldsen, S. (2021). Comparison of costs related to infant hospitalisations for spontaneous, induced and Caesarean births: population-based cohort study. Australian Health Review, 45(4), 418-424. [More Information]
Ho, E., Ferreira, M., Bauman, A., Hodges, P., Maher, C., Simic, M., Morton, R., Lonsdale, C., Li, Q., Baysari, M., Amorim, A., Ferreira, P., et al (2021). Effectiveness of a coordinated support system linking public hospitals to a health coaching service compared with usual care at discharge for patients with chronic low back pain: protocol for a randomised controlled trial. BMC Musculoskeletal Disorders, 22(1), 611. [More Information]
Juraskova, I., Laidsaar-Powell, R., Keast, R., Schofield, P., Costa, D., Kay, J., Turner, S., Koczwara, B., Saunders, C., Jefford, M., Boyle, F., White, K., Morton, R., Butt, Z., Butow, P., et al (2021). eTRIO trial: study protocol of a randomised controlled trial of online education modules to facilitate effective family caregiver involvement in oncology. BMJ Open, 11, e043224. [More Information]
So, C., Cust, A., Gordon, L., Morton, R., Canfell, K., Ngo, P., Dieng, M., McLoughlin, K., Watts, C. (2021). Health utilities for non‐melanoma skin cancers and pre‐ cancerous lesions: A systematic review. Skin Health and Disease, 1(3), e51. [More Information]
Kan, J., Dieng, M., Butow, P., Mireskandari, S., Tesson, S., Menzies, S., Costa, D., Morton, R., Mann, G., Cust, A., et al (2021). Identifying the ‘Active Ingredients' of an Effective Psychological Intervention to Reduce Fear of Cancer Recurrence: A Process Evaluation. Frontiers in Psychology, 12. [More Information]
Smit, A., Allen, M., Beswick, B., Butow, P., Dawkins, H., Dobbinson, S., Dunlop, K., Espinoza, D., Fenton, G., Kanetsky, P., Kirk, J., Lo, S., Mann, G., Reyes Marcelino, G., Morton, R., Newson, A., Trevena, L., Cust, A., et al (2021). Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial. Genetics in Medicine, 23(12), 2394-2403. [More Information]
Blood, Z., Tran, A., Caleo, L., Saw, R., Dieng, M., Shackleton, M., Soyer, H., Arnold, C., Mann, G., Morton, R. (2021). Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: A systematic review. BMJ Open, 11(2), e040751. [More Information]
Morton, R., Da Silva-Gane, M., Cass, A., Patterson, K., Yip, A., Handke, W., Webster, A. (2021). Interventions to aid employment for people on dialysis and their families. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2021 (6). [More Information]
Livingstone (nee Ratcliffe), A., Milne, D., Dempsey, K., Muscat, D., Menzies, A., Howard, K., Stockler, M., Morton, R. (2021). Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners. The Patient, 14(5), 635-647. [More Information]
Wyld, M., Morton, R., Aouad, L., Magliano, D., Polkinghorne, K., Chadban, S. (2021). The impact of comorbid chronic kidney disease and diabetes on health-related quality-of-life: a 12-year community cohort study. Nephrology Dialysis Transplantation, 36(6), 1048-1056. [More Information]
Felmingham, C., Adler, N., Ge, Z., Morton, R., Janda, M., Mar, V. (2021). The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World. American Journal of Clinical Dermatology, 22(2), 233-242. [More Information]
van der Veer, S., Couchoud, C., Morton, R. (2021). The role of kidney registries in expediting large-scale collection of patient-reported outcome measures for people with chronic kidney disease. Clinical Kidney Journal, 14(6), 1495-1503. [More Information]
Shah, K., Elder, D., Nguyen, M., Turner, L., Doyle, M., Woldendorp, K., Seco, M., Law, C., Wilson, M., Keech, A., Ng, M., Morton, R. (2021). Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study. Heart, Lung, and Circulation, 30(12), 1918-1928. [More Information]
Hure, A., Ramanathan, S., Deeming, S., Figtree, G., Jennings, G., Webster, J., Morton, R., Redfern, J., Doyle, K., Nicholls, S., et al (2021). Translation and Impact of Funded Australian Cardiovascular Research: A Review With Perspective. Heart, Lung, and Circulation, 30(10), 1442-1448. [More Information]
van der Tol, A., Stel, V., Jager, K., Lameire, N., Morton, R., Van Biesen, W., Vanholder, R. (2020). A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies. Nephrology Dialysis Transplantation, 35(6), 979-986. [More Information]
Livingstone, A., Morton, R. (2020). ASO Author Reflections: Important Factors for Adjuvant Immunotherapy Treatment Decisions for Stage II-IV Melanoma Patients and Their Clinicians. Annals of Surgical Oncology, 27(2), 585-586. [More Information]
Watts, C., Smith, A., Robinson, S., Chang, C., Goumas, C., Schmid, H., Kelly, J., Hong, A., Scolyer, R., Long, G., Spillane, A., Morton, R., Saw, R., Varey, A., Mann, G., Thompson, J., Cust, A., et al (2020). Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management. Australian Journal of General Practice, 49(6), 355-362. [More Information]
Dieng, M., Morton, R., Costa, D., Butow, P., Menzies, S., Lo, S., Mann, G., Cust, A., Kasparian, N. (2020). Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomized controlled trial. Asia-Pacific Journal of Clinical Oncology, 182(4), 860-868. [More Information]
Van Biesen, W., Jha, V., Abu-Alfa, A., Andreoli, S., Ashuntantang, G., Bernieh, B., Brown, E., Chen, Y., Coppo, R., Couchoud, C., Morton, R., et al (2020). Considerations on equity in management of end-stage kidney disease in low- and middle-income countries. Kidney International Supplements, 10(1), e63-e71. [More Information]
Tran, A., Fogarty, G., Nowak, A., Diaby, V., Hong, A., Watts, C., Morton, R. (2020). Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases. Applied Health Economics and Health Policy, 18(5), 679-687. [More Information]
Duncanson, E., Bennett, P., Viecelli, A., Dansie, K., Handke, W., Jaure, A., Palmer, S., Jesudason, S., McDonald, S., Morton, R. (2020). Feasibility and acceptability of e-PROMs data capture and feedback among patients receiving haemodialysis in the Symptom monitoring with Feedback Trial (SWIFT) pilot: Protocol for a qualitative study in Australia. BMJ Open, 10(11), e039014. [More Information]
Rapport, F., Smith, A., Cust, A., Mann, G., Watts, C., Gyorki, D., Henderson, M., Hong, A., Kelly, J., Long, G., Morton, R., Saw, R., Scolyer, R., Spillane, A., Thompson, J., et al (2020). Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: Protocol paper for a mixed methods study. BMJ Open, 10(2), e032636. [More Information]
Morton, R., Shah, K. (2020). Kidney health in the context of economic development. Nature Reviews Nephrology, 17(1), 5-6. [More Information]
Grimison, P., Mersiades, T., Kirby, A., Lintzeris, N., Morton, R., Haber, P., Olver, I., Walsh, A., McGregor, I., Cheung, Y., Simes, R., Stockler, M., et al (2020). Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Annals of Oncology, 31(11), 1553-1560. [More Information]
Livingstone (nee Ratcliffe), A., Agarwal, A., Stockler, M., Menzies, A., Howard, K., Morton, R. (2020). Preferences for Immunotherapy in Melanoma: A Systematic Review. Annals of Surgical Oncology, 27(2), 571-584. [More Information]
Shah, K., Murtagh, F., McGeechan, K., Crail, S., Burns, A., Morton, R. (2020). Quality of life among caregivers of people with end-stage kidney disease managed with dialysis or comprehensive conservative care. BMC Nephrology, 21(1), 160. [More Information]
Ying, T., Tran, A., Webster, A., Klarenbach, S., Gill, J., Chadban, S., Morton, R. (2020). Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis. American Journal of Kidney Diseases, 75(5), 693-704. [More Information]
Morton, R., Lioufas, N., Dansie, K., Palmer, S., Jose, M., Raj, R., Salmon, A., Sypek, M., Jaure, A., Ludlow, M., et al (2020). Use of Patient-Reported Outcome Measures and Patient-Reported Experience Measures in Renal units in Australia and New Zealand: a Cross-sectional Survey Study. Nephrology, 25(1), 14-21. [More Information]
Sellars, M., Morton, R., Clayton, J., Jaure, A., Mawren, D., Silvester, W., Power, D., Ma, R., Detering, K. (2019). A case-control study of end-of-life treatment preferences and costs following advance care planning for adults with end stage kidney disease. Nephrology, 24(2), 148-154. [More Information]
van der Tol, A., Lameire, N., Morton, R., van Biesen, W., Vanholder, R. (2019). An International Analysis of Dialysis Services Reimbursement. Clinical Journal of the American Society of Nephrology, 14(1), 84-93. [More Information]
Yeoh, S., Eastwood, J., Wright, I., Morton, R., Melhuish, E., Ward, M., Oei, J. (2019). Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis. JAMA Network Open, 2(7), 1-14. [More Information]
Dieng, M., Khanna, N., Kasparian, N., Costa, D., Butow, P., Menzies, S., Mann, G., Cust, A., Morton, R. (2019). Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma. Applied Health Economics and Health Policy, 17(5), 669-681. [More Information]
Sellars, M., Clayton, J., Detering, K., Jaure, A., Power, D., Morton, R. (2019). Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis. PloS One, 14(5), 1-11. [More Information]
Agbata, E., Morton, R., Bisoffi, Z., Bottieau, E., Greenaway, C., Biggs, B., Montero, N., Tran, A., Rowbotham, N., Arevalo-Rodriguez, I., et al (2019). Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 16(1), 1-41. [More Information]
Nijhuis, A., Dieng, M., Khanna, N., Lord, S., Dalton, J., Menzies, A., Turner, R., Allen, J., Saw, R., Nieweg, O., Thompson, J., Morton, R. (2019). False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma. Annals of Surgical Oncology, 26(6), 1860-1868. [More Information]
Morton, R., Sellars, M. (2019). From Patient-Centered to Person-Centered Care for Kidney Diseases. Clinical Journal of the American Society of Nephrology, 14(4), 623-625. [More Information]
Shah, K., Murtagh, F., McGeechan, K., Crail, S., Burns, A., Tran, A., Morton, R. (2019). Health-related quality of life and well-being in people over 75 years of age with end-stage kidney disease managed with dialysis or comprehensive conservative care: a cross-sectional study in the UK and Australia. BMJ Open, 9(5), 1-8. [More Information]
Sukul, N., Zhao, J., Fuller, D., Karaboyas, A., Bieber, B., Sloand, J., Subramanian, L., Johnson, D., Oliver, M., Tungsanga, K., Morton, R., et al (2019). Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS. BMC Nephrology, 20(1), 1-10. [More Information]
Dieng, M., Smit, A., Hersch, J., Morton, R., Cust, A., Irwig, L., Low, D., Low, C., Bell, K. (2019). Patients' Views About Skin Self-examination After Treatment for Localized Melanoma. JAMA Dermatology, 155(8), 914-921. [More Information]
Wong, M., Ninomiya, T., Liyanage, T., Sukkar, L., Hirakawa, Y., Wang, Y., Wyld, M., Morton, R., Chadban, S., Howard, K., et al (2019). Physical component Quality of life (QOL) reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 QOL: an AUSDiab analysis. Nephrology, 24(6), 605-614. [More Information]
Morton, R., Asher, R., Peyton, E., Tran, A., Smit, A., Butow, P., Kimlin, M., Dobbinson, S., Wordsworth, S., Keogh, L., Cust, A. (2019). Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention? Cancer Epidemiology, 61, 8-13. [More Information]
Morton, R., Thompson, J. (2019). Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia. BMJ Quality and Safety, 28(3), 253-254. [More Information]
Wyld, M., Morton, R., Clayton, P., Wong, M., Jardine, M., Polkinghorne, K., Chadban, S. (2019). The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study. Quality of Life Research, 28(8), 2081-2090. [More Information]
Guitera, P., Collgros, H., Madronio, C., Goumas, C., Mann, G., Watts, C., Pereira, A., Armstrong, B., Drummond, M., Morton, R., Scolyer, R., Menzies, S., Thompson, J., Cust, A. (2019). The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management. Australasian Journal of Dermatology, 60(2), 118-125. [More Information]
Lo, S., Hong, A., Haydu, L., Ahmed, T., Paton, E., Steel, V., Hruby, G., Tran, A., Morton, R., Nowak, A., Vardy, J., Dhillon, H., Scolyer, R., Thompson, J., Fogarty, G., et al (2019). Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan. Trials, 20(1), 1-13. [More Information]
Walker, R., Morton, R., Palmer, S., Marshall, M., Jaure, A., Howard, K. (2018). A Discrete Choice Study of Patient Preferences for Dialysis Modalities. Clinical Journal of the American Society of Nephrology, 13(1), 100-108. [More Information]
Watts, C., Wortley, S., Norris, S., Menzies, S., Guitera, P., Askie, L., Mann, G., Morton, R., Cust, A. (2018). A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia. Applied Health Economics and Health Policy, 16(2), 235-242. [More Information]
Wilson, A., Vento, M., Shah, P., Saugstad, O., Finer, N., Rich, W., Morton, R., Rabi, Y., Tarnow-Mordi, W., Suzuki, K., Oei, J., et al (2018). A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants. Acta Paediatrica, 107(1), 20-27. [More Information]
Tran, A., Fogarty, G., Nowak, A., Espinoza, D., Rowbotham, N., Stockler, M., Morton, R. (2018). A systematic review and meta-analysis of utility estimates in melanoma. British Journal of Dermatology, 178(2), 384-393. [More Information]
O’Halloran, P., Noble, H., Norwood, K., Maxwell, P., Shields, J., Fogarty, D., Murtagh, F., Morton, R., Brazil, K. (2018). Advance care planning with patients who have end-stage kidney disease: a systematic realist review. Journal of Pain and Symptom Management, 56(5), 795-807. [More Information]
Sellars, M., Clayton, J., Morton, R., Luckett, T., Silvester, W., Spencer, L., Pollock, C., Walker, R., Kerr, P., Jaure, A. (2018). An Interview Study of Patient and Caregiver Perspectives on Advance Care Planning in ESRD. American Journal of Kidney Diseases, 71(2), 216-224. [More Information]
Critselis, E., Vlahou, A., Stel, V., Morton, R. (2018). Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion. Nephrology Dialysis Transplantation, 33(3), 441-449. [More Information]
Read, R., Madronio, C., Cust, A., Goumas, C., Watts, C., Menzies, S., Curtin, A., Mann, G., Thompson, J., Morton, R. (2018). Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia. Annals of Surgical Oncology, 25(3), 617-625. [More Information]
Morton, R., Schlackow, I., Gray, A., Emberson, J., Herrington, W., Staplin, N., Reith, C., Howard, K., Landray, M., Cass, A., et al (2018). Impact of CKD on Household Income. Kidney International Reports, 3(3), 610-618. [More Information]
Hui, C., Dunn, J., Morton, R., Staub, L., Tran, A., Hargreaves, S., Greenaway, C., Biggs, B., Christensen, R., Pottie, K. (2018). Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 15(10), 1-13. [More Information]
Clark, M., Szczepura, A., Gumber, A., Howard, K., Moro, D., Morton, R. (2018). Measuring trade-offs in nephrology: a systematic review of discrete choice experiments and conjoint analysis studies. Nephrology Dialysis Transplantation, 33(2), 348-355. [More Information]
Mersiades, T., Tognela, A., Haber, P., Stockler, M., Lintzeris, N., Simes, R., McGregor, I., Olver, I., Allsop, D., Gedye, C., Kirby, A., Morton, R., Wong, N., Walsh, A., Grimison, P., et al (2018). Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV). BMJ Open, 8(9), 1-8. [More Information]
Lim, W., Morton, R., Turner, R., Jenkins, M., Guitera, P., Irwig, L., Webster, A., Dieng, M., Saw, R., Low, D., Bell, K., et al (2018). Patient preferences for follow-up after recent excision of a localized melanoma. JAMA Dermatology, 154(4), 420-427. [More Information]
Dieng, M., Kasparian, N., Cust, A., Costa, D., Tran, A., Butow, P., Menzies, S., Mann, G., Morton, R. (2018). Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma. JAMA Dermatology, 154(1), 52-59. [More Information]
Herzog, S., Shanahan, M., Grimison, P., Tran, A., Wong, N., Lintzeris, N., Simes, R., Stockler, M., Morton, R. (2018). Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis. PharmacoEconomics, 36(1), 67-78. [More Information]
Greenaway, C., Makarenko, I., Chakra, C., Alabdulkarim, B., Christensen, R., Palayew, A., Tran, A., Staub, L., Pareek, M., Meerpohl, J., Morton, R., et al (2018). The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 15(9), 1-24. [More Information]
Myran, D., Morton, R., Biggs, B., Veldhuijzen, I., Castelli, F., Tran, A., Staub, L., Agbata, E., Rahman, P., Pareek, M., et al (2018). The effectiveness and cost-effectiveness of screening for and vaccination against hepatitis B virus among migrants in the EU/EEA: A systematic review. International Journal of Environmental Research and Public Health, 15(9), 1-19. [More Information]
Pottie, K., Lotf, T., Kilzar, L., Howeiss, P., Rizk, N., Akl, E., Dias, S., Biggs, B., Christensen, R., Rahman, P., Tran, A., Rowbotham, N., Morton, R., et al (2018). The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 15(8), 1-23. [More Information]
Greenaway, C., Pareek, M., Chakra, C., Walji, M., Makarenko, I., Alabdulkarim, B., Hogan, C., McConnell, T., Scarfo, B., Christensen, R., Tran, A., Morton, R., et al (2018). The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review. Eurosurveillance, 23(14), 1-21. [More Information]
Smit, A., Newson, A., Morton, R., Kimlin, M., Keogh, L., Law, M., Kirk, J., Dobbinson, S., Kanetsky, P., Fenton, G., Butow, P., Trevena, L., Lo, S., Savard, J., Mann, G., Cust, A., et al (2018). The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors. Contemporary Clinical Trials, 70, 106-116. [More Information]
Lim, W., Turner, R., Morton, R., Jenkins, M., Irwig, L., Webster, A., Dieng, M., Saw, R., Guitera, P., Low, D., Bell, K., et al (2018). Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma. BMC Health Services Research, 18(1), 1-9. [More Information]
Walker, R., Marshall, R., Howard, K., Morton, R., Marshall, M. (2017). "Who matters most?": Clinician perspectives of influence and recommendation on home dialysis uptake. Nephrology, 22(12), 977-984. [More Information]
Smit, A., Espinoza, D., Newson, A., Morton, R., Fenton, G., Freeman, L., Dunlop, K., Butow, P., Law, M., Kimlin, M., Kirk, J., Mann, G., Cust, A., et al (2017). A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public. Cancer Epidemiology Biomarkers and Prevention, 26(2), 212-221. [More Information]
Luckett, T., Spencer, L., Morton, R., Pollock, C., Lam, L., Silvester, W., Sellars, M., Detering, K., Butow, P., Jaure, A., Clayton, J. (2017). Advance care planning in chronic kidney disease: A survey of current practice in Australia. Nephrology, 22(2), 139-149. [More Information]
Webster, A., Nagler, E., Morton, R., Masson, P. (2017). Chronic Kidney Disease. The Lancet, 389(10075), 1238-1252. [More Information]
Watts, C., Madronio, C., Morton, R., Goumas, C., Armstrong, B., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2017). Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study. JAMA Dermatology, 153(1), 23-29. [More Information]
Sellars, M., Jaure, A., Luckett, T., Morton, R., Pollock, C., Spencer, L., Silvester, W., Clayton, J. (2017). Clinicians’ Perspectives on Advance Care Planning for Patients With CKD in Australia: An Interview Study. American Journal of Kidney Diseases, 70(3), 315-323. [More Information]
Watts, C., Cust, A., Menzies, S., Mann, G., Morton, R. (2017). Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of Melanoma. Journal of Clinical Oncology, 35(1), 63-71. [More Information]
Watts, C., Madronio, C., Morton, R., Goumas, C., Armstrong, B., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2017). Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia. Australasian Journal of Dermatology, 58(4), 278-285. [More Information]
Smit, A., Keogh, L., Newson, A., Butow, P., Dunlop, K., Morton, R., Kirk, J., Espinoza, D., Cust, A. (2017). Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals? British Journal of Dermatology, 177(3), 779-790. [More Information]
Bell, K., Mehta, Y., Turner, R., Morton, R., Dieng, M., Saw, R., Guitera, P., McCaffery, K., Low, D., Low, C., Jenkins, M., Irwig, L., Webster, A. (2017). Fear of new or recurrent melanoma after treatment for localised melanoma. Psycho-Oncology, 26(11), 1784-1791. [More Information]
Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J., Lameire, N., Morton, R., Oberbauer, R., Postma, M., Tonelli, M., et al (2017). Further approaches to reduce the cost of renal replacement therapy. Nature Reviews Nephrology, 13(11), 720. [More Information]
Welch, V., Akl, E., Guyatt, G., Pottie, K., Eslava-Schmalbach, J., Ansari, M., de Beer, H., Briel, M., Dans, T., Morton, R., et al (2017). GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale. Journal of Clinical Epidemiology, 90, 59-67. [More Information]
Welch, V., Akl, E., Pottie, K., Ansari, M., Briel, M., Christensen, R., Dans, A., Dans, L., Eslava-Schmalbach, J., Morton, R., et al (2017). GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence. Journal of Clinical Epidemiology, 90, 76-83. [More Information]
Pottie, K., Welch, V., Morton, R., Akl, E., Eslava-Schmalbach, J., Katikireddi, V., Singh, J., Moja, L., Lang, E., Magrini, N., et al (2017). GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process. Journal of Clinical Epidemiology, 90, 84-91. [More Information]
Walker, R., Howard, K., Morton, R. (2017). Home hemodialysis: A comprehensive review of patient-centered and economic considerations. ClinicoEconomics and Outcome Research, 9, 149-161. [More Information]
Morton, R., Da Silva-Gane, M., Cass, A., Patterson, K., Yip, A., Handke, W., Webster, A. (2017). Interventions to aid employment for people on dialysis and their families (Protocol). Cochrane Database of Systematic Reviews, 2017 (7), 1-15. [More Information]
Walker, R., Walker, S., Morton, R., Jaure, A., Howard, K., Palmer, S. (2017). Maori patients' experiences and perspectives of chronic kidney disease: A New Zealand qualitative interview study. BMJ Open, 7(1), 1-9. [More Information]
Caskey, F., Morton, R. (2017). Optimising care for children with kidney disease. The Lancet, 389(10084), 2084-2086. [More Information]
Pottie, K., Mayhew, A., Morton, R., Greenaway, C., Akl, E., Rahman, P., Zenner, D., Pareek, M., Tugwell, P., Welch, V., et al (2017). Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems. BMJ Open, 7(9), 1-8. [More Information]
Dieng, M., Kasparian, N., Mireskandari, S., Butow, P., Costa, D., Morton, R., Mann, G., Menzies, S., Cust, A. (2017). Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial. BMJ Open, 7(e015195), 1-9. [More Information]
Morton, R., Tran, A., Vessey, J., Rowbotham, N., Winstanley, J., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Saw, R. (2017). Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications. Annals of Surgical Oncology, 24, 2071-2079. [More Information]
Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J., Lameire, N., Morton, R., Oberbauer, R., Postma, M., Tonelli, M., et al (2017). Reducing the costs of chronic kidney disease while delivering quality health care: A call to action. Nature Reviews Nephrology, 13(7), 393-409. [More Information]
Morton, R., Webster, A., McGeechan, K., Howard, K., Murtagh, F., Gray, N., Kerr, P., Germain, M., Snelling, P. (2016). Conservative management and end of life care in an Australian cohort with ESRD. Clinical Journal of the American Society of Nephrology, 11(12), 2195-2203. [More Information]
Morton, R. (2016). Do dialysis decision aids improve treatment decision-making? Peritoneal Dialysis International, 36(4), 359-361. [More Information]
Madronio, C., Armstrong, B., Watts, C., Goumas, C., Morton, R., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2016). Doctors' recognition and management of melanoma patients' risk: An Australian population-based study. Cancer Epidemiology, 45, 32-39. [More Information]
Dieng, M., Cust, A., Kasparian, N., Mann, G., Morton, R. (2016). Economic evaluations of psychosocial interventions in cancer: a systematic review. Psycho-Oncology, 25(12), 1380-1392. [More Information]
Jaure, A., Morton, R., Webster, A. (2016). How Qualitative Research Informs Clinical and Policy Decision Making in Transplantation: A Review. Transplantation, 100(9), 1997-2005. [More Information]
Morton, R., Schlackow, I., Staplin, N., Gray, A., Cass, A., Haynes, R., Emberson, J., Herrington, W., Landray, M., Baigent, C., et al (2016). Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD. American Journal of Kidney Diseases, 67(1), 31-39. [More Information]
Wyld, M., Chadban, S., Morton, R. (2016). Improving Our Understanding of Quality of Life in CKD. American Journal of Kidney Diseases, 67(6), 820-821. [More Information]
Walker, R., Howard, K., Morton, R., Palmer, S., Marshall, M., Jaure, A. (2016). Patient and caregiver values, beliefs and experiences when considering home dialysis as a treatment option: a semi-structured interview study. Nephrology Dialysis Transplantation, 31(1), 133-141. [More Information]
Howard, K., Morton, R. (2016). Patient Education and Choice of Peritoneal Dialysis. American Journal of Kidney Diseases, 68(3), 341-343. [More Information]
Dieng, M., Cust, A., Kasparian, N., Butow, P., Costa, D., Menzies, S., Mann, G., Morton, R. (2016). Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma. BMJ Open, 6(10), 1-8. [More Information]
Dieng, M., Butow, P., Costa, D., Morton, R., Menzies, S., Mireskandari, S., Tesson, S., Mann, G., Cust, A., Kasparian, N. (2016). Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. Journal of Clinical Oncology, 34(36), 4405-4414. [More Information]
Merom, D., Mathieu, E., Cerin, E., Morton, R., Simpson, J., Rissel, C., Anstey, K., Sherrington, C., Lord, S., Cumming, R. (2016). Social Dancing and Incidence of Falls in Older Adults: A Cluster Randomised Controlled Trial. PLoS Medicine, 13(8), 1-19. [More Information]
Murtagh, F., Burns, A., Moranne, O., Morton, R., Naicker, S. (2016). Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease. Clinical Journal of the American Society of Nephrology, 11(10), 1909-1914. [More Information]
Morton, R., Kurella Tamura, M., Coast, J., Davison, S. (2016). Supportive Care: Economic Considerations in Advanced Kidney Disease. Clinical Journal of the American Society of Nephrology, 11(10), 1915-1920. [More Information]
Walker, R., Howard, K., Jaure, A., Palmer, S., Marshall, M., Morton, R. (2016). The economic considerations of patients and caregivers in choice of dialysis modality. Hemodialysis International, 20(4), 634-642. [More Information]
Morton, R., Schlackow, I., Mihaylova, B., Staplin, N., Gray, A., Cass, A. (2016). The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review. Nephrology Dialysis Transplantation, 31(1), 46-56. [More Information]
Watts, C., Dieng, M., Morton, R., Mann, G., Menzies, S., Cust, A. (2015). Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. British Journal of Dermatology, 172(1), 33-47. [More Information]
Wyld, M., Lee, C., Zhou, X., White, S., Shaw, J., Morton, R., Colagiuri, S., Chadban, S. (2015). Cost to Government and Society of Chronic Kidney Disease Stage 1-5, a National Cohort Study. Internal Medicine Journal, 45(7), 741-747. [More Information]
Davison, S., Levin, A., Moss, A., Jha, V., Brown, E., Brennan, F., Murtagh, F., Naicker, S., Germain, M., O'Donoughe, D., Morton, R., et al (2015). Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney International, 88(3), 447-459. [More Information]
Howard, K., McFarlane, P., Marshall, M., Eastwood, D., Morton, R. (2015). Funding and planning: What you need to know for starting or expanding a home hemodialysis program. Hemodialysis International, 19(Suppl 1), S23-42. [More Information]
Memari, N., Hayen, A., Bell, K., Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Irwig, L., Turner, R. (2015). How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center? Annals of Surgical Oncology, 22(Supp 3), 1164-1171. [More Information]
Breckenridge, K., Bekker, H., Gibbons, E., van der Veer, S., Abbott, D., Briancon, S., Cullen, R., Graneata, L., Jager, K., Lonning, K., Morton, R., et al (2015). How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrology Dialysis Transplantation, 30(10), 1605-1614. [More Information]
Walker, R., Hanson, C., Palmer, S., Howard, K., Morton, R., Marshall, M., Jaure, A. (2015). Patient and Caregiver Perspectives on Home Hemodialysis: A Systematic Review. American Journal of Kidney Diseases, 65(3), 451-463. [More Information]
Walker, R., Morton, R., Jaure, A., Marshall, M., Palmer, S., Howard, K. (2015). Patient and caregiver preferences for home dialysis-The home first study: A protocol for qualitative interviews and discrete choice experiments. BMJ Open, 5(4), 1-6. [More Information]
Watts, C., Cust, A., Menzies, S., Coates, E., Mann, G., Morton, R. (2015). Specialized surveillance for individuals at high risk for melanoma a cost analysis of a high-risk clinic. JAMA Dermatology, 151(2), 178-186. [More Information]
Dieng, M., Kasparian, N., Morton, R., Mann, G., Butow, P., Menzies, S., Costa, D., Cust, A. (2015). The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease. BMC Psychology, 3(1), 1-13. [More Information]
Saw, R., Armstrong, B., Mason, R., Morton, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J. (2014). Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). BMC Cancer, 14, 1-10. [More Information]
Foote, C., Morton, R., Jardine, M., Gallagher, M., Brown, M., Howard, K., Cass, A. (2014). Considerations of Nephrologists when SuggestIng Dialysis in Elderly patients with Renal failure (CONSIDER): a discrete choice experiment. Nephrology Dialysis Transplantation, 29(12), 2302-2309. [More Information]
Morton, R. (2014). Essential inputs for studies of cost-effectiveness analysis in melanoma. British Journal of Dermatology, 171(6), 1294-1295. [More Information]
Wong, G., Howard, K., Webster, A., Morton, R., Chapman, J., Craig, J. (2014). How is health economics relevant to transplant clinicians? Transplantation, 98(2), 124-130. [More Information]
Asha, S., Chan, A., Walter, E., Kelly, P., Morton, R., Ajami, A., Wilson, R., Honneyman, D. (2014). Impact from point-of-care devices on emergency department patient processing times compared with central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis. Emergency Medicine Journal, 31(9), 714-719. [More Information]
Dieng, M., Watts, C., Kasparian, N., Morton, R., Mann, G., Cust, A. (2014). Improving subjective perception of personal cancer risk: systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer. Psycho-Oncology, 23(6), 613-625. [More Information]
Fortnum, D., Ludlow, M., Morton, R. (2014). Renal unit characteristics and patient education practices that predict a high prevalence of home-based dialysis in Australia. Nephrology, 19(9), 587-593. [More Information]
Walker, R., Marshall, M., Morton, R., McFarlane, P., Howard, K. (2014). The cost effectiveness of contemporary home haemodialysis modalities compared to facility haemodialysis: A systematic review of full economic evaluations. Nephrology, 19(8), 459-470. [More Information]
Wyld, M., Clayton, P., Morton, R., Chadban, S. (2013). Anti-Coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis. Nephrology, 18(12), 783-789. [More Information]
Walker, R., Fassett, R., Morton, R. (2013). ANZSN renal supportive care guidelines 2013: Research Issues in elderly patients: gaps in knowledge and suggested directions. Nephrology, 18(6), 439-441. [More Information]
Merom, D., Cumming, R., Mathieu, E., Anstey, K., Rissel, C., Simpson, J., Morton, R., Cerin, E., Sherrington, C., Lord, S. (2013). Can social dancing prevent falls in older adults? a protocol of the Dance, Aging, Cognition, Economics (DAnCE) fall prevention randomised controlled trial. BMC Public Health, 13(1), 1-9. [More Information]
Rychetnik, L., McCaffery, K., Morton, R., Thompson, J., Menzies, S., Irwig, L. (2013). Follow-Up of Early Stage Melanoma: Specialist Clinician Perspectives on the Functions of Follow-Up and Implications for Extending Follow-Up Intervals. Journal of Surgical Oncology, 107(5), 463-468. [More Information]
Morton, R., Rychetnik, L., McCaffery, K., Thompson, J., Irwig, L. (2013). Patients' perspectives of long-term follow-up for localised cutaneous melanoma. European Journal of Surgical Oncology, 39, 297-303. [More Information]
Rychetnik, L., McCaffery, K., Morton, R., Irwig, L. (2013). Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature. Psycho-Oncology, 22(4), 721-736. [More Information]
Walker, R., Fassett, R., Morton, R. (2013). Research issues in Elderly patients: gaps in knowledge and suggested directions. Nephrology, 18(6), 439-441. [More Information]
Wyld, M., Morton, R., Hayen, A., Howard, K., Webster, A. (2012). A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments. PLoS Medicine, 9(9), 1-10. [More Information]
Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Dialysis Modality Preference of Patients With CKD and Family Caregivers: A Discrete-Choice Study. American Journal of Kidney Diseases, 60(1), 102-111. [More Information]
Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ, 184(5), E277-E283. [More Information]
Morton, R., Turner, R., Howard, K., Snelling, P., Webster, A. (2012). Patients Who Plan for Conservative Care Rather Than Dialysis: A National Observational Study in Australia. American Journal of Kidney Diseases, 59(3), 419-427. [More Information]
Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Menzies, S., Irwig, L. (2012). Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care. BMC Health Services Research, 12, 1-9. [More Information]
Jaure, A., Morton, R., Howard, K., McTaggart, S., Craig, J. (2011). "When I had my transplant, I became normal." Adolescent perspectives on life after kidney transplantation. Pediatric Transplantation, 15(3), 285-293. [More Information]
Morton, R., Jaure, A., Webster, A., Snelling, P., Howard, K. (2011). Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrology, Dialysis, Transplantation, 26(12), 4038-4046. [More Information]
Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011). Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology, 29(35), 4641-4646. [More Information]
Jaure, A., Tjaden, L., Howard, K., Wong, G., Morton, R., Craig, J. (2011). Quality of Life of Adolescent Kidney Transplant Recipients. The Journal of Pediatrics, 159(4), 670-675. [More Information]
Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]
Jaure, A., Morton, R., Howard, K., McTaggart, S., Craig, J. (2010). 'When I had my transplant, I became normal.' adolescent perspectives on life after kidney transplantation. Nephrology, 15(S4), 64-64.
Morton, R., Howard, K., Thompson, J. (2010). In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma. Annals of Surgical Oncology, 17(2), 663-664. [More Information]
Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrology, Dialysis, Transplantation, doi: 10.1093/ndt/gfq555(unspecified), 1-9. [More Information]
Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology, 15(6), 649-652. [More Information]
Morton, R., Devitt, J., Howard, K., Anderson, K., Snelling, P., Cass, A. (2010). Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. American Journal of Kidney Diseases, 55(3), 431-440. [More Information]
Morton, R., Jaure, A., Howard, K., Snelling, P., Webster, A. (2010). The views of patients and carers in treatment decision making for chronic kidney disease: a systematic review of qualitative studies. BMJ, 340(7742), 1-10. [More Information]
Morton, R., Moustakas, J., Howard, K., Webster, A., Snelling, P. (2009). A national audit of information provided to new chronic kidney disease stage 4 & 5 patients: results from a pilot study. Renal Society of Australasia Journal, 5(3), 138-146.
Jaure, A., Morton, R., Howard, K., Craig, J. (2009). Adolescent Experiences Following Organ Transplantation: A Systematic Review of Qualitative Studies. The Journal of Pediatrics, 155(4), 542-549. [More Information]
Thompson, J., Morton, R. (2009). In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma. Annals of Surgical Oncology, 16(10), 2962-2963. [More Information]
Morton, R., Howard, K., Webster, A., Wong, G., Craig, J. (2009). The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrology, Dialysis, Transplantation, 24(7), 2258-2269. [More Information]
Morton, R., Craig, J., Thompson, J. (2009). The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients. Annals of Surgical Oncology, 16(3), 571-577. [More Information]
Morton, R., Howard, K., Thompson, J. (2008). The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma. Annals of Surgical Oncology, 16(4), 929-940. [More Information]
Uren, R., Howman-Giles, R., Chung, D., Morton, R., Thompson, J. (2006). The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 14(2), 899-905. [More Information]

show 188 more

Conferences

Jaure, A., Tjaden, L., Howard, K., Wong, G., Morton, R., Craig, J. (2011). Quality of Life of Adolescent Kidney Transplant Recipients. 2011 Transplantation Society of Australia and New Zealand (TSANZ), 29th Annual Scientific Meeting, Canberra, Australia.

By Year

Expand all

2025

Nikolovski, J., Kim, B., Morton, R., Mercieca-Bebber, R., Levesque, J., Tinsley, M., Sutherland, K., Rossiter, B., Fagan, M., Hartas, G., Rutherford, C. (2025). Strategies to promote the completion of patient-reported outcome measures by culturally and linguistically diverse and Indigenous Peoples in clinical care settings: A systematic review. Quality of Life Research. [More Information]

2024

Hole, B., Coast, J., Caskey, F., Selman, L., Rooshenas, L., Kimpton, G., Snead, C., Field, A., Morton, R. (2024). A choice experiment of older patients’ preferences for kidney failure treatments. Kidney International. [More Information]
Burns, B., Marschner, I., Eggins, R., Buscher, H., Morton, R., Bendall, J., Keech, A., Dennis, M. (2024). A randomized trial of expedited intra-arrest transfer versus more extended on-scene resuscitation for refractory out of hospital cardiac arrest: Rationale and design of the EVIDENCE trial. American Heart Journal, 267, 22-32. [More Information]
Nikolovski, J., Morton, R., Mercieca-Bebber, R., Armstrong, M., Hartas, G., Rossiter, B., Fagan, M., Tinsley, M., Snyder, C., Aiyegbusi, O., Rutherford, C., et al (2024). Acceptability and timing considerations when administering patient-reported outcome measures (PROMs) among people with chronic health conditions who are culturally and linguistically diverse (CALD): a qualitative study protocol. BMJ Open, 14(9), e083346. [More Information]
Mersiades, T., Solomon, B., Thomas, D., Lee, C., Parry, M., Sebastian, L., Ballinger, M., Collignon, E., Turnbull, O., Yip, S., Morton, R., Brown, C., Itchins, M., Simes, R., Pavlakis, N., et al (2024). ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue. Future Oncology, 20(7), 361-371. [More Information]
Shah, K., Hedley, J., Robledo, K., Wyld, M., Webster, A., Morton, R. (2024). Cost-effectiveness of Accepting Kidneys from Deceased Donors with Common Cancers - A Modeling Study. Transplantation, 108(8), e187-e197. [More Information]
Siriwardana, A., Hoffman, A., Morton, R., Smyth, B., Brown, M. (2024). Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients. Value in Health, 27(4), 469-477. [More Information]
Yi, T., O'Hara, D., Smyth, B., Jardine, M., Levin, A., Morton, R. (2024). Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research. Canadian journal of kidney health and disease, 11. [More Information]
Desson, Z., Figtree, G., Webster, J., Jennings, G., Redfern, J., Nicholls, S., McNamara, M., Deeming, S., Doyle, K., Ramanathan, S., Morton, R., et al (2024). Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study. Journal of Human Hypertension, 38(2), 177-186. [More Information]
De La Mata, N., Khou, V., Hedley, J., Kelly, P., Morton, R., Webster, A., Wyburn, K. (2024). Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist. Nephrology Dialysis Transplantation, 39(7), 1138-1149. [More Information]
Williams, J., Bell, K., Morton, R., Dieng, M. (2024). Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review. Value in Health, 27(6), 794-804. [More Information]
Martin, A., Cust, A., Lo, S., Morton, R., Kasparian, N., Collgros Totosaus, H., Teh, N., Martin, L., Guitera, P. (2024). Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single-arm, feasibility study of a clinical intervention at two tertiary centres (MOBILEMEL). Journal of the European Academy of Dermatology and Venereology. [More Information]
Ni, Y., Watts, C., Scolyer, R., Madronio, C., Armstrong, B., Morton, R., Menzies, S., Mann, G., Thompson, J., Cust, A., Lo, S. (2024). Prognosis for people with multiple primary melanomas compared with a single primary melanoma. Journal Of The American Academy Of Dermatology, 90(1), 170-174. [More Information]
Jeyaprakash, P., Loh, H., Boyle, A., Ford, T., Porter, T., Negishi, K., Pathan, F., Ozawa, K., Robledo, K., Shah, K., Morton, R., Yu, C., Madronio, C., Hallani, H. (2024). Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial. American Heart Journal, 275, 163-172. [More Information]
Douglas, C., Alexeev, S., Middleton, S., Gardner, G., Kelly, P., McInnes, E., Rihari-Thomas, J., Windsor, C., Morton, R. (2024). Transforming nursing assessment in acute hospitals: A cluster randomised controlled trial of an evidence-based nursing core assessment (the ENCORE trial). International Journal of Nursing Studies, 151, 104690. [More Information]

show 11 more

2023

Wei, Z., Gilbert, Y., Thananjeyan, A., Cope, J., Morton, R., Li, A., Pham, C., Ward, M., Oei, J. (2023). A Systematic Review of Clinical Practice Guidelines for Neonatal Abstinence Syndrome. Children, 10(10). [More Information]
Shah, K., Wyld, M., Hedley, J., Waller, K., De La Mata, N., Webster, A., Morton, R. (2023). Cost-effectiveness of Kidney Transplantation From Donors at Increased Risk of Blood-borne Virus Infection Transmission. Transplantation, 107(9), 2028-2042. [More Information]
Taylor, W., Tuffaha, H., Hawley, C., Peyton, P., Higgins, A., Scuffham, P., Nemeh, F., Balagurunathan, A., Hansen, P., Jacques, A., Morton, R. (2023). Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals. PloS One, 18(2023-12-12 00:00:00). [More Information]
Agarwal, N., Shah, K., Dansie, K., Bennett, P., Greenham, L., Brown, C., Smyth, B., McDonald, S., Jesudason, S., Viecelli, A., Morton, R. (2023). Feasibility of Symptom monitoring WIth Feedback Trial (SWIFT) for adults on hemodialysis: a registry-based cluster randomized pilot trial. BMC Nephrology, 24(1). [More Information]
Callander, E., Tarnow-Mordi, W., Morton, R., Mol, B., Kumar, S. (2023). Intrapartum use of sildenafil citrate to prevent fetal compromise and emergency operative birth in term pregnancies in the United Kingdom and Australia: A preliminary cost-effectiveness analysis. International Journal of Gynecology & Obstetrics. [More Information]
Law, C., Cust, A., Smit, A., Trevena, L., Fernandez Penas, P., Nieweg, O., Menzies, A., Wordsworth, S., Morton, R. (2023). Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine, 25(12), 100970. [More Information]
Mehrotra, R., Davison, S., Farrington, K., Flythe, J., Foo, M., Madero, M., Morton, R., Tsukamoto, Y., Unruh, M., Cheung, M., et al (2023). Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 104(3), 441-454. [More Information]
Livingstone (nee Ratcliffe), A., Howard, K., Menzies, A., Long, G., Stockler, M., Morton, R. (2023). Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma - A Discrete Choice Experiment. The Patient, 16(5), 497-513. [More Information]
Blake, S., Guitera, P., Cust, A., Galea, C., Lo, S., Scolyer, R., Armstrong, B., Thompson, J., Menzies, S., Madronio, C., Morton, R., Mann, G., Watts, C. (2023). The association of dermatologist demographic density with melanoma survival in New South Wales, Australia. Australasian Journal of Dermatology, 64(3), 425-429. [More Information]

show 6 more

2022

Law, C., Stevenson, A., Solomon, M., Hague, W., Simes, R., Morton, R. (2022). ASO Author Reflections: Is laparoscopic-Assisted Surgery More Costly than Traditional Open Resection for Rectal Cancer Treatment? Annals of Surgical Oncology, 29(3), 1935-1936. [More Information]
Mahumud, R., Janda, M., Soyer, H., Fernandez Penas, P., Mar, V., Morton, R. (2022). Assessing the value of precision medicine health technologies to detect and manage melanoma. Medical Journal of Australia, 217(6), 275-278. [More Information]
Nagarajan, S., Lewis, V., Halcomb, E., Rhee, J., Morton, R., Mitchell, G., Tieman, J., Phillips, J., Detering, K., Gavin, J., Clayton, J. (2022). Barriers and facilitators to nurse-led advance care planning and palliative care practice change in primary healthcare: a qualitative study. Australian Journal of Primary Health, 28(2), 151-157. [More Information]
Siu, H., Carey, S., Jones, L., Morton, R., Koh, C. (2022). Detailed analysis of in-hospital costs for adult patients with type III intestinal failure: A single-center study with global implications. Journal of Parenteral and Enteral Nutrition, 46(3), 685-692. [More Information]
Jobson, D., Roffey, B., Best, R., Button-Sloan, A., Cossio, D., Evans, S., Shang, C., Moore, J., Arnold, C., Mann, G., Morton, R., et al (2022). Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper. BMJ Open, 12(9). [More Information]
Mitchell, P., Morton, R., Hiligsmann, M., Husbands, S., Coast, J. (2022). Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands. The European Journal of Health Economics. [More Information]
Cohen, P., Webb, P., King, M., Obermair, A., Gebski, V., Butow, P., Morton, R., Lawson, W., Yates, P., Campbell, R., Brand, A., et al (2022). Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer. International Journal of Gynecological Cancer, 32(4), 560-565. [More Information]
Law, C., Stevenson, A., Solomon, M., Hague, W., Wilson, K., Simes, R., Morton, R. (2022). Healthcare Costs of Laparoscopic versus Open Surgery for Rectal Cancer Patients in the First 12 Months: A Secondary Endpoint Analysis of the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT). Annals of Surgical Oncology, 29(3), 1923-1934. [More Information]
Greenham, L., Bennett, P., Dansie, K., Mister, R., Smyth, B., Westall, P., Herzog, S., Brown, C., Simes, R., Morton, R., et al (2022). The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis. Trials, 23(1), 419. [More Information]
Dempsey, K., Ferguson, C., Walczak, A., Middleton, S., Levi, C., Morton, R. (2022). Which strategies support the effective use of clinical practice guidelines and clinical quality registry data to inform health service delivery? A systematic review. Systematic Reviews, 11(1). [More Information]

show 7 more

2021

de Jong, Y., van der Willik, E., Milders, J., Voorend, C., Morton, R., Dekker, F., Meuleman, Y., van Diepen, M. (2021). A meta-review demonstrates improved reporting quality of qualitative reviews following the publication of COREQ- and ENTREQ-checklists, regardless of modest uptake. BMC Medical Research Methodology, 21(1), 184. [More Information]
Dieng, M., Morton, R. (2021). ASO Author Reflections: Longitudinal Diagnostic Accuracy of Surveillance Imaging in Resected Stage III Melanoma Patients. Annals of Surgical Oncology, 28(8), 4570-4571. [More Information]
Watts, C., McLoughlin, K., Goumas, C., Van Kemenade, C., Aitken, J., Soyer, H., Fernandez Penas, P., Guitera, P., Scolyer, R., Morton, R., Menzies, S., Caruana, M., Kang, Y., Mann, G., Madronio, C., Armstrong, B., Thompson, J., Cust, A., et al (2021). Association between Melanoma Detected during Routine Skin Checks and Mortality. JAMA Dermatology, 157(12), 1425-1436. [More Information]
Mahumud, R., Sahle, B., Owusu-Addo, E., Chen, W., Morton, R., Renzaho, A. (2021). Association of dietary intake, physical activity, and sedentary behaviours with overweight and obesity among 282,213 adolescents in 89 low and middle income to high-income countries. International Journal of Obesity, 45(11), 2404-2418. [More Information]
Khou, V., De La Mata, N., Morton, R., Kelly, P., Webster, A. (2021). Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand. Nephrology Dialysis Transplantation, 36(8), 1527-1537. [More Information]
Owen, K., Ibiebele, I., Simpson, J., Morton, R., Morris, J., Torvaldsen, S. (2021). Comparison of costs related to infant hospitalisations for spontaneous, induced and Caesarean births: population-based cohort study. Australian Health Review, 45(4), 418-424. [More Information]
Ho, E., Ferreira, M., Bauman, A., Hodges, P., Maher, C., Simic, M., Morton, R., Lonsdale, C., Li, Q., Baysari, M., Amorim, A., Ferreira, P., et al (2021). Effectiveness of a coordinated support system linking public hospitals to a health coaching service compared with usual care at discharge for patients with chronic low back pain: protocol for a randomised controlled trial. BMC Musculoskeletal Disorders, 22(1), 611. [More Information]
Juraskova, I., Laidsaar-Powell, R., Keast, R., Schofield, P., Costa, D., Kay, J., Turner, S., Koczwara, B., Saunders, C., Jefford, M., Boyle, F., White, K., Morton, R., Butt, Z., Butow, P., et al (2021). eTRIO trial: study protocol of a randomised controlled trial of online education modules to facilitate effective family caregiver involvement in oncology. BMJ Open, 11, e043224. [More Information]
So, C., Cust, A., Gordon, L., Morton, R., Canfell, K., Ngo, P., Dieng, M., McLoughlin, K., Watts, C. (2021). Health utilities for non‐melanoma skin cancers and pre‐ cancerous lesions: A systematic review. Skin Health and Disease, 1(3), e51. [More Information]
Kan, J., Dieng, M., Butow, P., Mireskandari, S., Tesson, S., Menzies, S., Costa, D., Morton, R., Mann, G., Cust, A., et al (2021). Identifying the ‘Active Ingredients' of an Effective Psychological Intervention to Reduce Fear of Cancer Recurrence: A Process Evaluation. Frontiers in Psychology, 12. [More Information]
Smit, A., Allen, M., Beswick, B., Butow, P., Dawkins, H., Dobbinson, S., Dunlop, K., Espinoza, D., Fenton, G., Kanetsky, P., Kirk, J., Lo, S., Mann, G., Reyes Marcelino, G., Morton, R., Newson, A., Trevena, L., Cust, A., et al (2021). Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial. Genetics in Medicine, 23(12), 2394-2403. [More Information]
Blood, Z., Tran, A., Caleo, L., Saw, R., Dieng, M., Shackleton, M., Soyer, H., Arnold, C., Mann, G., Morton, R. (2021). Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: A systematic review. BMJ Open, 11(2), e040751. [More Information]
Morton, R., Da Silva-Gane, M., Cass, A., Patterson, K., Yip, A., Handke, W., Webster, A. (2021). Interventions to aid employment for people on dialysis and their families. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2021 (6). [More Information]
Livingstone (nee Ratcliffe), A., Milne, D., Dempsey, K., Muscat, D., Menzies, A., Howard, K., Stockler, M., Morton, R. (2021). Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners. The Patient, 14(5), 635-647. [More Information]
Wyld, M., Morton, R., Aouad, L., Magliano, D., Polkinghorne, K., Chadban, S. (2021). The impact of comorbid chronic kidney disease and diabetes on health-related quality-of-life: a 12-year community cohort study. Nephrology Dialysis Transplantation, 36(6), 1048-1056. [More Information]
Felmingham, C., Adler, N., Ge, Z., Morton, R., Janda, M., Mar, V. (2021). The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World. American Journal of Clinical Dermatology, 22(2), 233-242. [More Information]
van der Veer, S., Couchoud, C., Morton, R. (2021). The role of kidney registries in expediting large-scale collection of patient-reported outcome measures for people with chronic kidney disease. Clinical Kidney Journal, 14(6), 1495-1503. [More Information]
Shah, K., Elder, D., Nguyen, M., Turner, L., Doyle, M., Woldendorp, K., Seco, M., Law, C., Wilson, M., Keech, A., Ng, M., Morton, R. (2021). Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study. Heart, Lung, and Circulation, 30(12), 1918-1928. [More Information]
Hure, A., Ramanathan, S., Deeming, S., Figtree, G., Jennings, G., Webster, J., Morton, R., Redfern, J., Doyle, K., Nicholls, S., et al (2021). Translation and Impact of Funded Australian Cardiovascular Research: A Review With Perspective. Heart, Lung, and Circulation, 30(10), 1442-1448. [More Information]

show 16 more

2020

van der Tol, A., Stel, V., Jager, K., Lameire, N., Morton, R., Van Biesen, W., Vanholder, R. (2020). A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies. Nephrology Dialysis Transplantation, 35(6), 979-986. [More Information]
Livingstone, A., Morton, R. (2020). ASO Author Reflections: Important Factors for Adjuvant Immunotherapy Treatment Decisions for Stage II-IV Melanoma Patients and Their Clinicians. Annals of Surgical Oncology, 27(2), 585-586. [More Information]
Watts, C., Smith, A., Robinson, S., Chang, C., Goumas, C., Schmid, H., Kelly, J., Hong, A., Scolyer, R., Long, G., Spillane, A., Morton, R., Saw, R., Varey, A., Mann, G., Thompson, J., Cust, A., et al (2020). Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management. Australian Journal of General Practice, 49(6), 355-362. [More Information]
Dieng, M., Morton, R., Costa, D., Butow, P., Menzies, S., Lo, S., Mann, G., Cust, A., Kasparian, N. (2020). Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomized controlled trial. Asia-Pacific Journal of Clinical Oncology, 182(4), 860-868. [More Information]
Van Biesen, W., Jha, V., Abu-Alfa, A., Andreoli, S., Ashuntantang, G., Bernieh, B., Brown, E., Chen, Y., Coppo, R., Couchoud, C., Morton, R., et al (2020). Considerations on equity in management of end-stage kidney disease in low- and middle-income countries. Kidney International Supplements, 10(1), e63-e71. [More Information]
Tran, A., Fogarty, G., Nowak, A., Diaby, V., Hong, A., Watts, C., Morton, R. (2020). Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases. Applied Health Economics and Health Policy, 18(5), 679-687. [More Information]
Duncanson, E., Bennett, P., Viecelli, A., Dansie, K., Handke, W., Jaure, A., Palmer, S., Jesudason, S., McDonald, S., Morton, R. (2020). Feasibility and acceptability of e-PROMs data capture and feedback among patients receiving haemodialysis in the Symptom monitoring with Feedback Trial (SWIFT) pilot: Protocol for a qualitative study in Australia. BMJ Open, 10(11), e039014. [More Information]
Rapport, F., Smith, A., Cust, A., Mann, G., Watts, C., Gyorki, D., Henderson, M., Hong, A., Kelly, J., Long, G., Morton, R., Saw, R., Scolyer, R., Spillane, A., Thompson, J., et al (2020). Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: Protocol paper for a mixed methods study. BMJ Open, 10(2), e032636. [More Information]
Morton, R., Shah, K. (2020). Kidney health in the context of economic development. Nature Reviews Nephrology, 17(1), 5-6. [More Information]
Grimison, P., Mersiades, T., Kirby, A., Lintzeris, N., Morton, R., Haber, P., Olver, I., Walsh, A., McGregor, I., Cheung, Y., Simes, R., Stockler, M., et al (2020). Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Annals of Oncology, 31(11), 1553-1560. [More Information]
Livingstone (nee Ratcliffe), A., Agarwal, A., Stockler, M., Menzies, A., Howard, K., Morton, R. (2020). Preferences for Immunotherapy in Melanoma: A Systematic Review. Annals of Surgical Oncology, 27(2), 571-584. [More Information]
Shah, K., Murtagh, F., McGeechan, K., Crail, S., Burns, A., Morton, R. (2020). Quality of life among caregivers of people with end-stage kidney disease managed with dialysis or comprehensive conservative care. BMC Nephrology, 21(1), 160. [More Information]
Ying, T., Tran, A., Webster, A., Klarenbach, S., Gill, J., Chadban, S., Morton, R. (2020). Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis. American Journal of Kidney Diseases, 75(5), 693-704. [More Information]
Morton, R., Lioufas, N., Dansie, K., Palmer, S., Jose, M., Raj, R., Salmon, A., Sypek, M., Jaure, A., Ludlow, M., et al (2020). Use of Patient-Reported Outcome Measures and Patient-Reported Experience Measures in Renal units in Australia and New Zealand: a Cross-sectional Survey Study. Nephrology, 25(1), 14-21. [More Information]

show 11 more

2019

Sellars, M., Morton, R., Clayton, J., Jaure, A., Mawren, D., Silvester, W., Power, D., Ma, R., Detering, K. (2019). A case-control study of end-of-life treatment preferences and costs following advance care planning for adults with end stage kidney disease. Nephrology, 24(2), 148-154. [More Information]
van der Tol, A., Lameire, N., Morton, R., van Biesen, W., Vanholder, R. (2019). An International Analysis of Dialysis Services Reimbursement. Clinical Journal of the American Society of Nephrology, 14(1), 84-93. [More Information]
Yeoh, S., Eastwood, J., Wright, I., Morton, R., Melhuish, E., Ward, M., Oei, J. (2019). Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis. JAMA Network Open, 2(7), 1-14. [More Information]
Dieng, M., Khanna, N., Kasparian, N., Costa, D., Butow, P., Menzies, S., Mann, G., Cust, A., Morton, R. (2019). Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma. Applied Health Economics and Health Policy, 17(5), 669-681. [More Information]
Sellars, M., Clayton, J., Detering, K., Jaure, A., Power, D., Morton, R. (2019). Costs and outcomes of advance care planning and end-of-life care for older adults with end-stage kidney disease: A person-centred decision analysis. PloS One, 14(5), 1-11. [More Information]
Agbata, E., Morton, R., Bisoffi, Z., Bottieau, E., Greenaway, C., Biggs, B., Montero, N., Tran, A., Rowbotham, N., Arevalo-Rodriguez, I., et al (2019). Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 16(1), 1-41. [More Information]
Nijhuis, A., Dieng, M., Khanna, N., Lord, S., Dalton, J., Menzies, A., Turner, R., Allen, J., Saw, R., Nieweg, O., Thompson, J., Morton, R. (2019). False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma. Annals of Surgical Oncology, 26(6), 1860-1868. [More Information]
Morton, R., Sellars, M. (2019). From Patient-Centered to Person-Centered Care for Kidney Diseases. Clinical Journal of the American Society of Nephrology, 14(4), 623-625. [More Information]
Shah, K., Murtagh, F., McGeechan, K., Crail, S., Burns, A., Tran, A., Morton, R. (2019). Health-related quality of life and well-being in people over 75 years of age with end-stage kidney disease managed with dialysis or comprehensive conservative care: a cross-sectional study in the UK and Australia. BMJ Open, 9(5), 1-8. [More Information]
Sukul, N., Zhao, J., Fuller, D., Karaboyas, A., Bieber, B., Sloand, J., Subramanian, L., Johnson, D., Oliver, M., Tungsanga, K., Morton, R., et al (2019). Patient-reported advantages and disadvantages of peritoneal dialysis: results from the PDOPPS. BMC Nephrology, 20(1), 1-10. [More Information]
Dieng, M., Smit, A., Hersch, J., Morton, R., Cust, A., Irwig, L., Low, D., Low, C., Bell, K. (2019). Patients' Views About Skin Self-examination After Treatment for Localized Melanoma. JAMA Dermatology, 155(8), 914-921. [More Information]
Wong, M., Ninomiya, T., Liyanage, T., Sukkar, L., Hirakawa, Y., Wang, Y., Wyld, M., Morton, R., Chadban, S., Howard, K., et al (2019). Physical component Quality of life (QOL) reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 QOL: an AUSDiab analysis. Nephrology, 24(6), 605-614. [More Information]
Morton, R., Asher, R., Peyton, E., Tran, A., Smit, A., Butow, P., Kimlin, M., Dobbinson, S., Wordsworth, S., Keogh, L., Cust, A. (2019). Risk attitudes and sun protection behaviour: Can behaviour be altered by using a melanoma genomic risk intervention? Cancer Epidemiology, 61, 8-13. [More Information]
Morton, R., Thompson, J. (2019). Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia. BMJ Quality and Safety, 28(3), 253-254. [More Information]
Wyld, M., Morton, R., Clayton, P., Wong, M., Jardine, M., Polkinghorne, K., Chadban, S. (2019). The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study. Quality of Life Research, 28(8), 2081-2090. [More Information]
Guitera, P., Collgros, H., Madronio, C., Goumas, C., Mann, G., Watts, C., Pereira, A., Armstrong, B., Drummond, M., Morton, R., Scolyer, R., Menzies, S., Thompson, J., Cust, A. (2019). The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management. Australasian Journal of Dermatology, 60(2), 118-125. [More Information]
Lo, S., Hong, A., Haydu, L., Ahmed, T., Paton, E., Steel, V., Hruby, G., Tran, A., Morton, R., Nowak, A., Vardy, J., Dhillon, H., Scolyer, R., Thompson, J., Fogarty, G., et al (2019). Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan. Trials, 20(1), 1-13. [More Information]

show 14 more

2018

Walker, R., Morton, R., Palmer, S., Marshall, M., Jaure, A., Howard, K. (2018). A Discrete Choice Study of Patient Preferences for Dialysis Modalities. Clinical Journal of the American Society of Nephrology, 13(1), 100-108. [More Information]
Watts, C., Wortley, S., Norris, S., Menzies, S., Guitera, P., Askie, L., Mann, G., Morton, R., Cust, A. (2018). A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia. Applied Health Economics and Health Policy, 16(2), 235-242. [More Information]
Wilson, A., Vento, M., Shah, P., Saugstad, O., Finer, N., Rich, W., Morton, R., Rabi, Y., Tarnow-Mordi, W., Suzuki, K., Oei, J., et al (2018). A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants. Acta Paediatrica, 107(1), 20-27. [More Information]
Tran, A., Fogarty, G., Nowak, A., Espinoza, D., Rowbotham, N., Stockler, M., Morton, R. (2018). A systematic review and meta-analysis of utility estimates in melanoma. British Journal of Dermatology, 178(2), 384-393. [More Information]
O’Halloran, P., Noble, H., Norwood, K., Maxwell, P., Shields, J., Fogarty, D., Murtagh, F., Morton, R., Brazil, K. (2018). Advance care planning with patients who have end-stage kidney disease: a systematic realist review. Journal of Pain and Symptom Management, 56(5), 795-807. [More Information]
Sellars, M., Clayton, J., Morton, R., Luckett, T., Silvester, W., Spencer, L., Pollock, C., Walker, R., Kerr, P., Jaure, A. (2018). An Interview Study of Patient and Caregiver Perspectives on Advance Care Planning in ESRD. American Journal of Kidney Diseases, 71(2), 216-224. [More Information]
Critselis, E., Vlahou, A., Stel, V., Morton, R. (2018). Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion. Nephrology Dialysis Transplantation, 33(3), 441-449. [More Information]
Read, R., Madronio, C., Cust, A., Goumas, C., Watts, C., Menzies, S., Curtin, A., Mann, G., Thompson, J., Morton, R. (2018). Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia. Annals of Surgical Oncology, 25(3), 617-625. [More Information]
Morton, R., Schlackow, I., Gray, A., Emberson, J., Herrington, W., Staplin, N., Reith, C., Howard, K., Landray, M., Cass, A., et al (2018). Impact of CKD on Household Income. Kidney International Reports, 3(3), 610-618. [More Information]
Hui, C., Dunn, J., Morton, R., Staub, L., Tran, A., Hargreaves, S., Greenaway, C., Biggs, B., Christensen, R., Pottie, K. (2018). Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 15(10), 1-13. [More Information]
Clark, M., Szczepura, A., Gumber, A., Howard, K., Moro, D., Morton, R. (2018). Measuring trade-offs in nephrology: a systematic review of discrete choice experiments and conjoint analysis studies. Nephrology Dialysis Transplantation, 33(2), 348-355. [More Information]
Mersiades, T., Tognela, A., Haber, P., Stockler, M., Lintzeris, N., Simes, R., McGregor, I., Olver, I., Allsop, D., Gedye, C., Kirby, A., Morton, R., Wong, N., Walsh, A., Grimison, P., et al (2018). Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV). BMJ Open, 8(9), 1-8. [More Information]
Lim, W., Morton, R., Turner, R., Jenkins, M., Guitera, P., Irwig, L., Webster, A., Dieng, M., Saw, R., Low, D., Bell, K., et al (2018). Patient preferences for follow-up after recent excision of a localized melanoma. JAMA Dermatology, 154(4), 420-427. [More Information]
Dieng, M., Kasparian, N., Cust, A., Costa, D., Tran, A., Butow, P., Menzies, S., Mann, G., Morton, R. (2018). Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma. JAMA Dermatology, 154(1), 52-59. [More Information]
Herzog, S., Shanahan, M., Grimison, P., Tran, A., Wong, N., Lintzeris, N., Simes, R., Stockler, M., Morton, R. (2018). Systematic Review of the Costs and Benefits of Prescribed Cannabis-Based Medicines for the Management of Chronic Illness: Lessons from Multiple Sclerosis. PharmacoEconomics, 36(1), 67-78. [More Information]
Greenaway, C., Makarenko, I., Chakra, C., Alabdulkarim, B., Christensen, R., Palayew, A., Tran, A., Staub, L., Pareek, M., Meerpohl, J., Morton, R., et al (2018). The Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 15(9), 1-24. [More Information]
Myran, D., Morton, R., Biggs, B., Veldhuijzen, I., Castelli, F., Tran, A., Staub, L., Agbata, E., Rahman, P., Pareek, M., et al (2018). The effectiveness and cost-effectiveness of screening for and vaccination against hepatitis B virus among migrants in the EU/EEA: A systematic review. International Journal of Environmental Research and Public Health, 15(9), 1-19. [More Information]
Pottie, K., Lotf, T., Kilzar, L., Howeiss, P., Rizk, N., Akl, E., Dias, S., Biggs, B., Christensen, R., Rahman, P., Tran, A., Rowbotham, N., Morton, R., et al (2018). The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review. International Journal of Environmental Research and Public Health, 15(8), 1-23. [More Information]
Greenaway, C., Pareek, M., Chakra, C., Walji, M., Makarenko, I., Alabdulkarim, B., Hogan, C., McConnell, T., Scarfo, B., Christensen, R., Tran, A., Morton, R., et al (2018). The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review. Eurosurveillance, 23(14), 1-21. [More Information]
Smit, A., Newson, A., Morton, R., Kimlin, M., Keogh, L., Law, M., Kirk, J., Dobbinson, S., Kanetsky, P., Fenton, G., Butow, P., Trevena, L., Lo, S., Savard, J., Mann, G., Cust, A., et al (2018). The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors. Contemporary Clinical Trials, 70, 106-116. [More Information]
Lim, W., Turner, R., Morton, R., Jenkins, M., Irwig, L., Webster, A., Dieng, M., Saw, R., Guitera, P., Low, D., Bell, K., et al (2018). Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma. BMC Health Services Research, 18(1), 1-9. [More Information]

show 18 more

2017

Walker, R., Marshall, R., Howard, K., Morton, R., Marshall, M. (2017). "Who matters most?": Clinician perspectives of influence and recommendation on home dialysis uptake. Nephrology, 22(12), 977-984. [More Information]
Smit, A., Espinoza, D., Newson, A., Morton, R., Fenton, G., Freeman, L., Dunlop, K., Butow, P., Law, M., Kimlin, M., Kirk, J., Mann, G., Cust, A., et al (2017). A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public. Cancer Epidemiology Biomarkers and Prevention, 26(2), 212-221. [More Information]
Luckett, T., Spencer, L., Morton, R., Pollock, C., Lam, L., Silvester, W., Sellars, M., Detering, K., Butow, P., Jaure, A., Clayton, J. (2017). Advance care planning in chronic kidney disease: A survey of current practice in Australia. Nephrology, 22(2), 139-149. [More Information]
Webster, A., Nagler, E., Morton, R., Masson, P. (2017). Chronic Kidney Disease. The Lancet, 389(10075), 1238-1252. [More Information]
Watts, C., Madronio, C., Morton, R., Goumas, C., Armstrong, B., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2017). Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study. JAMA Dermatology, 153(1), 23-29. [More Information]
Sellars, M., Jaure, A., Luckett, T., Morton, R., Pollock, C., Spencer, L., Silvester, W., Clayton, J. (2017). Clinicians’ Perspectives on Advance Care Planning for Patients With CKD in Australia: An Interview Study. American Journal of Kidney Diseases, 70(3), 315-323. [More Information]
Watts, C., Cust, A., Menzies, S., Mann, G., Morton, R. (2017). Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of Melanoma. Journal of Clinical Oncology, 35(1), 63-71. [More Information]
Watts, C., Madronio, C., Morton, R., Goumas, C., Armstrong, B., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2017). Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia. Australasian Journal of Dermatology, 58(4), 278-285. [More Information]
Smit, A., Keogh, L., Newson, A., Butow, P., Dunlop, K., Morton, R., Kirk, J., Espinoza, D., Cust, A. (2017). Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals? British Journal of Dermatology, 177(3), 779-790. [More Information]
Bell, K., Mehta, Y., Turner, R., Morton, R., Dieng, M., Saw, R., Guitera, P., McCaffery, K., Low, D., Low, C., Jenkins, M., Irwig, L., Webster, A. (2017). Fear of new or recurrent melanoma after treatment for localised melanoma. Psycho-Oncology, 26(11), 1784-1791. [More Information]
Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J., Lameire, N., Morton, R., Oberbauer, R., Postma, M., Tonelli, M., et al (2017). Further approaches to reduce the cost of renal replacement therapy. Nature Reviews Nephrology, 13(11), 720. [More Information]
Welch, V., Akl, E., Guyatt, G., Pottie, K., Eslava-Schmalbach, J., Ansari, M., de Beer, H., Briel, M., Dans, T., Morton, R., et al (2017). GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationale. Journal of Clinical Epidemiology, 90, 59-67. [More Information]
Welch, V., Akl, E., Pottie, K., Ansari, M., Briel, M., Christensen, R., Dans, A., Dans, L., Eslava-Schmalbach, J., Morton, R., et al (2017). GRADE equity guidelines 3: considering health equity in GRADE guideline development: rating the certainty of synthesized evidence. Journal of Clinical Epidemiology, 90, 76-83. [More Information]
Pottie, K., Welch, V., Morton, R., Akl, E., Eslava-Schmalbach, J., Katikireddi, V., Singh, J., Moja, L., Lang, E., Magrini, N., et al (2017). GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process. Journal of Clinical Epidemiology, 90, 84-91. [More Information]
Walker, R., Howard, K., Morton, R. (2017). Home hemodialysis: A comprehensive review of patient-centered and economic considerations. ClinicoEconomics and Outcome Research, 9, 149-161. [More Information]
Morton, R., Da Silva-Gane, M., Cass, A., Patterson, K., Yip, A., Handke, W., Webster, A. (2017). Interventions to aid employment for people on dialysis and their families (Protocol). Cochrane Database of Systematic Reviews, 2017 (7), 1-15. [More Information]
Walker, R., Walker, S., Morton, R., Jaure, A., Howard, K., Palmer, S. (2017). Maori patients' experiences and perspectives of chronic kidney disease: A New Zealand qualitative interview study. BMJ Open, 7(1), 1-9. [More Information]
Caskey, F., Morton, R. (2017). Optimising care for children with kidney disease. The Lancet, 389(10084), 2084-2086. [More Information]
Pottie, K., Mayhew, A., Morton, R., Greenaway, C., Akl, E., Rahman, P., Zenner, D., Pareek, M., Tugwell, P., Welch, V., et al (2017). Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems. BMJ Open, 7(9), 1-8. [More Information]
Dieng, M., Kasparian, N., Mireskandari, S., Butow, P., Costa, D., Morton, R., Mann, G., Menzies, S., Cust, A. (2017). Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial. BMJ Open, 7(e015195), 1-9. [More Information]
Morton, R., Tran, A., Vessey, J., Rowbotham, N., Winstanley, J., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Saw, R. (2017). Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications. Annals of Surgical Oncology, 24, 2071-2079. [More Information]
Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J., Lameire, N., Morton, R., Oberbauer, R., Postma, M., Tonelli, M., et al (2017). Reducing the costs of chronic kidney disease while delivering quality health care: A call to action. Nature Reviews Nephrology, 13(7), 393-409. [More Information]

show 19 more

2016

Morton, R., Webster, A., McGeechan, K., Howard, K., Murtagh, F., Gray, N., Kerr, P., Germain, M., Snelling, P. (2016). Conservative management and end of life care in an Australian cohort with ESRD. Clinical Journal of the American Society of Nephrology, 11(12), 2195-2203. [More Information]
Morton, R. (2016). Do dialysis decision aids improve treatment decision-making? Peritoneal Dialysis International, 36(4), 359-361. [More Information]
Madronio, C., Armstrong, B., Watts, C., Goumas, C., Morton, R., Curtin, A., Menzies, S., Mann, G., Thompson, J., Cust, A. (2016). Doctors' recognition and management of melanoma patients' risk: An Australian population-based study. Cancer Epidemiology, 45, 32-39. [More Information]
Dieng, M., Cust, A., Kasparian, N., Mann, G., Morton, R. (2016). Economic evaluations of psychosocial interventions in cancer: a systematic review. Psycho-Oncology, 25(12), 1380-1392. [More Information]
Jaure, A., Morton, R., Webster, A. (2016). How Qualitative Research Informs Clinical and Policy Decision Making in Transplantation: A Review. Transplantation, 100(9), 1997-2005. [More Information]
Morton, R., Schlackow, I., Staplin, N., Gray, A., Cass, A., Haynes, R., Emberson, J., Herrington, W., Landray, M., Baigent, C., et al (2016). Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD. American Journal of Kidney Diseases, 67(1), 31-39. [More Information]
Wyld, M., Chadban, S., Morton, R. (2016). Improving Our Understanding of Quality of Life in CKD. American Journal of Kidney Diseases, 67(6), 820-821. [More Information]
Walker, R., Howard, K., Morton, R., Palmer, S., Marshall, M., Jaure, A. (2016). Patient and caregiver values, beliefs and experiences when considering home dialysis as a treatment option: a semi-structured interview study. Nephrology Dialysis Transplantation, 31(1), 133-141. [More Information]
Howard, K., Morton, R. (2016). Patient Education and Choice of Peritoneal Dialysis. American Journal of Kidney Diseases, 68(3), 341-343. [More Information]
Dieng, M., Cust, A., Kasparian, N., Butow, P., Costa, D., Menzies, S., Mann, G., Morton, R. (2016). Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma. BMJ Open, 6(10), 1-8. [More Information]
Dieng, M., Butow, P., Costa, D., Morton, R., Menzies, S., Mireskandari, S., Tesson, S., Mann, G., Cust, A., Kasparian, N. (2016). Psychoeducational intervention to reduce fear of cancer recurrence in people at high risk of developing another primary melanoma: results of a randomized controlled trial. Journal of Clinical Oncology, 34(36), 4405-4414. [More Information]
Merom, D., Mathieu, E., Cerin, E., Morton, R., Simpson, J., Rissel, C., Anstey, K., Sherrington, C., Lord, S., Cumming, R. (2016). Social Dancing and Incidence of Falls in Older Adults: A Cluster Randomised Controlled Trial. PLoS Medicine, 13(8), 1-19. [More Information]
Murtagh, F., Burns, A., Moranne, O., Morton, R., Naicker, S. (2016). Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease. Clinical Journal of the American Society of Nephrology, 11(10), 1909-1914. [More Information]
Morton, R., Kurella Tamura, M., Coast, J., Davison, S. (2016). Supportive Care: Economic Considerations in Advanced Kidney Disease. Clinical Journal of the American Society of Nephrology, 11(10), 1915-1920. [More Information]
Walker, R., Howard, K., Jaure, A., Palmer, S., Marshall, M., Morton, R. (2016). The economic considerations of patients and caregivers in choice of dialysis modality. Hemodialysis International, 20(4), 634-642. [More Information]
Morton, R., Schlackow, I., Mihaylova, B., Staplin, N., Gray, A., Cass, A. (2016). The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review. Nephrology Dialysis Transplantation, 31(1), 46-56. [More Information]

show 13 more

2015

Watts, C., Dieng, M., Morton, R., Mann, G., Menzies, S., Cust, A. (2015). Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. British Journal of Dermatology, 172(1), 33-47. [More Information]
Wyld, M., Lee, C., Zhou, X., White, S., Shaw, J., Morton, R., Colagiuri, S., Chadban, S. (2015). Cost to Government and Society of Chronic Kidney Disease Stage 1-5, a National Cohort Study. Internal Medicine Journal, 45(7), 741-747. [More Information]
Davison, S., Levin, A., Moss, A., Jha, V., Brown, E., Brennan, F., Murtagh, F., Naicker, S., Germain, M., O'Donoughe, D., Morton, R., et al (2015). Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney International, 88(3), 447-459. [More Information]
Howard, K., McFarlane, P., Marshall, M., Eastwood, D., Morton, R. (2015). Funding and planning: What you need to know for starting or expanding a home hemodialysis program. Hemodialysis International, 19(Suppl 1), S23-42. [More Information]
Memari, N., Hayen, A., Bell, K., Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Irwig, L., Turner, R. (2015). How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center? Annals of Surgical Oncology, 22(Supp 3), 1164-1171. [More Information]
Breckenridge, K., Bekker, H., Gibbons, E., van der Veer, S., Abbott, D., Briancon, S., Cullen, R., Graneata, L., Jager, K., Lonning, K., Morton, R., et al (2015). How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrology Dialysis Transplantation, 30(10), 1605-1614. [More Information]
Walker, R., Hanson, C., Palmer, S., Howard, K., Morton, R., Marshall, M., Jaure, A. (2015). Patient and Caregiver Perspectives on Home Hemodialysis: A Systematic Review. American Journal of Kidney Diseases, 65(3), 451-463. [More Information]
Walker, R., Morton, R., Jaure, A., Marshall, M., Palmer, S., Howard, K. (2015). Patient and caregiver preferences for home dialysis-The home first study: A protocol for qualitative interviews and discrete choice experiments. BMJ Open, 5(4), 1-6. [More Information]
Watts, C., Cust, A., Menzies, S., Coates, E., Mann, G., Morton, R. (2015). Specialized surveillance for individuals at high risk for melanoma a cost analysis of a high-risk clinic. JAMA Dermatology, 151(2), 178-186. [More Information]
Dieng, M., Kasparian, N., Morton, R., Mann, G., Butow, P., Menzies, S., Costa, D., Cust, A. (2015). The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease. BMC Psychology, 3(1), 1-13. [More Information]

show 7 more

2014

Saw, R., Armstrong, B., Mason, R., Morton, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J. (2014). Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). BMC Cancer, 14, 1-10. [More Information]
Foote, C., Morton, R., Jardine, M., Gallagher, M., Brown, M., Howard, K., Cass, A. (2014). Considerations of Nephrologists when SuggestIng Dialysis in Elderly patients with Renal failure (CONSIDER): a discrete choice experiment. Nephrology Dialysis Transplantation, 29(12), 2302-2309. [More Information]
Morton, R. (2014). Essential inputs for studies of cost-effectiveness analysis in melanoma. British Journal of Dermatology, 171(6), 1294-1295. [More Information]
Wong, G., Howard, K., Webster, A., Morton, R., Chapman, J., Craig, J. (2014). How is health economics relevant to transplant clinicians? Transplantation, 98(2), 124-130. [More Information]
Asha, S., Chan, A., Walter, E., Kelly, P., Morton, R., Ajami, A., Wilson, R., Honneyman, D. (2014). Impact from point-of-care devices on emergency department patient processing times compared with central laboratory testing of blood samples: a randomised controlled trial and cost-effectiveness analysis. Emergency Medicine Journal, 31(9), 714-719. [More Information]
Dieng, M., Watts, C., Kasparian, N., Morton, R., Mann, G., Cust, A. (2014). Improving subjective perception of personal cancer risk: systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer. Psycho-Oncology, 23(6), 613-625. [More Information]
Morton, R., Webster, A. (2014). Quality of Life in Chronic Kidney Disease. In Mustafa Arici (Eds.), Management of Chronic Kidney Disease, (pp. 487-499). Berlin: Springer-Verlag. [More Information]
Fortnum, D., Ludlow, M., Morton, R. (2014). Renal unit characteristics and patient education practices that predict a high prevalence of home-based dialysis in Australia. Nephrology, 19(9), 587-593. [More Information]
Walker, R., Marshall, M., Morton, R., McFarlane, P., Howard, K. (2014). The cost effectiveness of contemporary home haemodialysis modalities compared to facility haemodialysis: A systematic review of full economic evaluations. Nephrology, 19(8), 459-470. [More Information]

show 6 more

2013

Wyld, M., Clayton, P., Morton, R., Chadban, S. (2013). Anti-Coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis. Nephrology, 18(12), 783-789. [More Information]
Walker, R., Fassett, R., Morton, R. (2013). ANZSN renal supportive care guidelines 2013: Research Issues in elderly patients: gaps in knowledge and suggested directions. Nephrology, 18(6), 439-441. [More Information]
Merom, D., Cumming, R., Mathieu, E., Anstey, K., Rissel, C., Simpson, J., Morton, R., Cerin, E., Sherrington, C., Lord, S. (2013). Can social dancing prevent falls in older adults? a protocol of the Dance, Aging, Cognition, Economics (DAnCE) fall prevention randomised controlled trial. BMC Public Health, 13(1), 1-9. [More Information]
Rychetnik, L., McCaffery, K., Morton, R., Thompson, J., Menzies, S., Irwig, L. (2013). Follow-Up of Early Stage Melanoma: Specialist Clinician Perspectives on the Functions of Follow-Up and Implications for Extending Follow-Up Intervals. Journal of Surgical Oncology, 107(5), 463-468. [More Information]
Morton, R., Rychetnik, L., McCaffery, K., Thompson, J., Irwig, L. (2013). Patients' perspectives of long-term follow-up for localised cutaneous melanoma. European Journal of Surgical Oncology, 39, 297-303. [More Information]
Rychetnik, L., McCaffery, K., Morton, R., Irwig, L. (2013). Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature. Psycho-Oncology, 22(4), 721-736. [More Information]
Walker, R., Fassett, R., Morton, R. (2013). Research issues in Elderly patients: gaps in knowledge and suggested directions. Nephrology, 18(6), 439-441. [More Information]

show 4 more

2012

Wyld, M., Morton, R., Hayen, A., Howard, K., Webster, A. (2012). A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments. PLoS Medicine, 9(9), 1-10. [More Information]
Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Dialysis Modality Preference of Patients With CKD and Family Caregivers: A Discrete-Choice Study. American Journal of Kidney Diseases, 60(1), 102-111. [More Information]
Morton, R., Snelling, P., Webster, A., Rose, J., Masterson, R., Johnson, D., Howard, K. (2012). Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ, 184(5), E277-E283. [More Information]
Morton, R., Turner, R., Howard, K., Snelling, P., Webster, A. (2012). Patients Who Plan for Conservative Care Rather Than Dialysis: A National Observational Study in Australia. American Journal of Kidney Diseases, 59(3), 419-427. [More Information]
Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Menzies, S., Irwig, L. (2012). Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care. BMC Health Services Research, 12, 1-9. [More Information]

show 2 more

2011

Jaure, A., Morton, R., Howard, K., McTaggart, S., Craig, J. (2011). "When I had my transplant, I became normal." Adolescent perspectives on life after kidney transplantation. Pediatric Transplantation, 15(3), 285-293. [More Information]
Morton, R., Jaure, A., Webster, A., Snelling, P., Howard, K. (2011). Characteristics of dialysis important to patients and family caregivers: a mixed methods approach. Nephrology, Dialysis, Transplantation, 26(12), 4038-4046. [More Information]
Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011). Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology, 29(35), 4641-4646. [More Information]
Jaure, A., Tjaden, L., Howard, K., Wong, G., Morton, R., Craig, J. (2011). Quality of Life of Adolescent Kidney Transplant Recipients. The Journal of Pediatrics, 159(4), 670-675. [More Information]
Jaure, A., Tjaden, L., Howard, K., Wong, G., Morton, R., Craig, J. (2011). Quality of Life of Adolescent Kidney Transplant Recipients. 2011 Transplantation Society of Australia and New Zealand (TSANZ), 29th Annual Scientific Meeting, Canberra, Australia.
Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]

show 3 more

2010

Jaure, A., Morton, R., Howard, K., McTaggart, S., Craig, J. (2010). 'When I had my transplant, I became normal.' adolescent perspectives on life after kidney transplantation. Nephrology, 15(S4), 64-64.
Morton, R., Howard, K., Thompson, J. (2010). In Reply: Cost Effectiveness of Staging Procedures in Patients with Stage I/II Melanoma. Annals of Surgical Oncology, 17(2), 663-664. [More Information]
Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients. Nephrology, Dialysis, Transplantation, doi: 10.1093/ndt/gfq555(unspecified), 1-9. [More Information]
Morton, R., Howard, K., Webster, A., Snelling, P. (2010). Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease. Nephrology, 15(6), 649-652. [More Information]
Morton, R., Devitt, J., Howard, K., Anderson, K., Snelling, P., Cass, A. (2010). Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. American Journal of Kidney Diseases, 55(3), 431-440. [More Information]
Morton, R., Jaure, A., Howard, K., Snelling, P., Webster, A. (2010). The views of patients and carers in treatment decision making for chronic kidney disease: a systematic review of qualitative studies. BMJ, 340(7742), 1-10. [More Information]

show 3 more

2009

Morton, R., Moustakas, J., Howard, K., Webster, A., Snelling, P. (2009). A national audit of information provided to new chronic kidney disease stage 4 & 5 patients: results from a pilot study. Renal Society of Australasia Journal, 5(3), 138-146.
Jaure, A., Morton, R., Howard, K., Craig, J. (2009). Adolescent Experiences Following Organ Transplantation: A Systematic Review of Qualitative Studies. The Journal of Pediatrics, 155(4), 542-549. [More Information]
Thompson, J., Morton, R. (2009). In Reply: Cost-Effectiveness of Sentinel Node Biopsy for Melanoma. Annals of Surgical Oncology, 16(10), 2962-2963. [More Information]
Morton, R., Howard, K., Webster, A., Wong, G., Craig, J. (2009). The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrology, Dialysis, Transplantation, 24(7), 2258-2269. [More Information]
Morton, R., Craig, J., Thompson, J. (2009). The Role of Surveillance Chest X-Rays in the Follow-Up of High-Risk Melanoma Patients. Annals of Surgical Oncology, 16(3), 571-577. [More Information]

show 2 more

2008

Morton, R., Howard, K., Thompson, J. (2008). The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma. Annals of Surgical Oncology, 16(4), 929-940. [More Information]

2006

Uren, R., Howman-Giles, R., Chung, D., Morton, R., Thompson, J. (2006). The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma. Annals of Surgical Oncology, 14(2), 899-905. [More Information]

Selected Grants

2023

A novel regimen to treat the commonest form of drug resistant tuberculosis: the FLIRT Trial, Fox G, Marks G, Menzies R, Marais B, Nhung N, Behr M, Marschner I, Johnston J, Morton R, Nguyen T, National Health and Medical Research Council (NHMRC)/Clinical Trials and Cohort Studies

2022

Strengthening Healthcare Systems with Patient Reported Outcome Measures (PROMs), Morton R, Rutherford C, Mercieca-Bebber R, Martin A, King M, National Health and Medical Research Council (NHMRC)/Partnership Projects

2021

Personalised Immunotherapy Program - Precision immunotherapies for multiple solid tumours using a biomarker driven adaptive enrichment clinical trials platform, Wilmott J, Long G, Scolyer R, Boyer M, Lo S, Menzies A, Morton R, Esteves Domingues Pires da Silva I, Cooper W, Cust A, Gide T, Cancer Institute NSW/Translational Program Grant
Skin Imaging and Precision Diagnosis, Janda M, Soyer H, Mar V, Fernandez Penas P, Morton R, Cust A, Wolfe R, Scolyer R, Caffery L, Ge Z, National Health and Medical Research Council (NHMRC)/Centres of Research Excellence
Reconceiving early detection of melanoma, Fernandez Penas P, Mar V, Janda M, Cust A, Morton R, Scolyer R, National Health and Medical Research Council (NHMRC)/Clinical Trials and Cohort Studies
NADINA Phase 3 trial comparing response driven neo-adjuvant combination of ipilimumab nivolumab versus adjuvant nivolumab, Long G, Scolyer R, McArthur G, Menzies A, Spillane A, Carlino M, Gyorki D, Saw R, Lo S, Morton R, Department of Health and Aged Care (Federal - administered by NHMRC)/2020 Efficient Use of Existing Medicines

2020

Embedding economics for cost-effective melanoma prevention, diagnosis and treatment, Morton R, National Health and Medical Research Council (NHMRC)/Investigator Grant
Assessing diagnostic accuracy for melanoma with compared to without access to Melanoma Surveillance Photography in high-risk individuals, Mar V, Cust A, Soyer H, Morton R, Wolfe R, Guitera P, White P, Janda M, Fishburn P, Kelly J, Department of Health and Aged Care (Federal)/MRFF - Preventive and Public Health Research - Targeted Health System & Community Organisation
The Get Healthy Coaching Service to reduce the burden of low back pain: effectiveness, cost effectiveness, and implementation, Ferreira P, Ferreira M, Bauman A, Hodges P, Maher C, Simic M, Morton R, Lonsdale C, Li Q, Baysari M, National Health and Medical Research Council (NHMRC)/Partnership Projects
Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A randomised controlled trial COBRRA, Chen V, Castellucci L, Brighton T, Tran H, Rodger M, Le Gal G, Kahn S, Simes R, Reddel C, Morton R, Department of Health and Aged Care (Federal)/MRFF - International Clinical Trials Collaborations Program
Maximising Organ Donor offer Utility System-wide the MODUS study, Webster A, Wyburn K, Morton R, McCaffery K, Kelly P, Clayton P, Muscat D, De La Mata N, National Health and Medical Research Council (NHMRC)/Partnership Projects

2019

ACRF National Centre of Excellence for Melanoma Imaging and Diagnosis - NSW eHealth Implementation Project Officer, Fernandez Penas P, Menzies S, Scolyer R, Guitera P, Cust A, Morton R, Australian Cancer Research Foundation/Research Support
PRIORITY TRIAL - Preoperative exercise for patients undergoing major abdominal cancer surgery: A Multicentre Randomised controlled Trial, Steffens D, Young J, Solomon M, Riedel B, Morton R, Denehy L, Heriot A, Koh C, Li Q, Bauman A, National Health and Medical Research Council (NHMRC)/Clinical Trials and Cohort Studies
COLchicine CARDIovascular Outcomes in Acute Coronary Syndrome COLCARDIO-ACS Study, Keech A, Patel S, Hillis G, Nicholls S, Thompson P, Newby D, Simes R, Morton R, Gebski V, Psaltis P, National Health and Medical Research Council (NHMRC)/Clinical Trials and Cohort Studies
ACRF Australian Centre of Excellence for Melanoma Imaging and Diagnosis (ACEMID), Fernandez Penas P, Guitera P, Scolyer R, Menzies S, Cust A, Morton R, Mann G, Soyer P, Mar V, Janda M, McCormack C, Aitken J, Grey L, Caffery L, Wolfe R, Australian Cancer Research Foundation/Research Support

2018

Improving high-value care in cancer and cardiovascular disease through economic evaluation alongside randomised trials, Morton R, DVC Research/Robinson Fellowships (SIF)
Can Symptom monitoring With Feedback to clinicians improve the lives of people on dialysis SWIFT, Morton R, McDonald S, Jose M, Brown C, Laranjo L, Bennett P, Palmer S, Caskey F, Couchoud C, National Health and Medical Research Council (NHMRC)/Project Grants
Symptom monitoring WIth Feedback Trial SWIFT pilot: A feasibility and acceptability study of ANZDATA E-PROMs data capture and feedback, Morton R, Kidney Health Australia/Research Grants
Economic Evaluation of Transcatheter Aortic Valve Implantation TAVI versus Surgical Aortic Valve Replacement SAVR in adults of all risk categories - Part 1, Morton R, Ng M, Keech A, Edwards Lifesciences/Research Grant

2017

Incorporating patient reported outcome measures (PROMs) into clinical registries, Morton R, National Health and Medical Research Council (NHMRC)/Translating Research into Practice (TRIP) Fellowship
Bridging Support Fellowship- Morton, Morton R, DVC Research/Bridging Support Fellowship
Transforming nursing assessment in acute hospitals: a cluster randomised controlled trial of an evidence-based core assessment protocol the ENCORE Trial, Douglas C, Kelly P, Morton R, National Health and Medical Research Council (NHMRC)/Project Grants
Centre of Research Excellence in Melanoma: Person, tumour and system-focussed knowledge to drive better outcomes in melanoma, Cust A, Mann G, Scolyer R, Braithwaite J, Kelly J, Morton R, Spillane A, Saw R, Henderson M, Yang J, National Health and Medical Research Council (NHMRC)/Centres of Research Excellence
Transforming protein quantitation technology to improve cancer diagnosis and treatment decisions, Reddel R, Robinson P, Balleine R, Bowling F, Dalla Pozza L, deFazio A, Harnett P, Mann G, Morton R, Spillane A, Cancer Institute NSW/Translational Program Grant
Computed tomography (CT) and positron emission tomography (PET)/CT surveillance imaging in asymptomatic Stage III melanoma patients - a prospective cohort study of clinical benefit and economic implications, Morton R, Thompson J, Emmett L, Nieweg O, Nieweg O, Turner R, Lord S, Lord S, Cancer Australia/Priority Driven Collaborative Cancer Research Scheme

2016

Improving skin cancer prevention: motivating preventive behaviours using knowledge of personalised genomic risk of melanoma, Cust A, Newson A, Morton R, Kimlin M, Keogh L, Law M, Kirk J, Dobbinson S, Kanetsky P, National Health and Medical Research Council (NHMRC)/Project Grants
Supporting provision of palliative care and advance care planning in general practice: a toolkit and training package targeting practice nurses, Morton R, Department of Health and Aged Care (Federal)/Chronic Disease Prevention and Service Improvement Fund Grant
Supporting provision of palliative care and advance care planning in general practice: a toolkit and training package targeting practice nurses, Clayton J, Shaw T, Morton R, Halcomb E, Rhee J, Mitchell G, Phillips J, Department of Health/Research Grant

2015

Translating our knowledge of genomics to improve skin cancer prevention: a pilot randomized controlled trial to evaluate whether knowledge of personal genetic risk of melanoma motivates behaviour change, Cust A, Newson A, Kimlin M, Kirk J, Keogh L, Law M, Morton R, Williams G, Butow P, Dobbinson S, DVC Research/SPARC Implementation - Cancer

2014

Evaluation of Groin Lymphandenectomy Extent for metastatic Melanoma Inguinal or Ilio-inguinal Lymphandenectomy for metastatic melanoma to groin lymph nodes and no pelvic disease on PET/CT Scan - a randomised controlled trial, Spillane A, Henderson M, King M, Henderson M, Morton R, Allan C, Cancer Council NSW/Research Project Grants

2013

Investigating barriers and facilitators to advance care planning for dialysis and pre-dialysis patients, Clayton J, Pollock C, Luckett T, Morton R, Silvester W, Detering K, Spencer L, Kidney Health Australia/Research Support
Analysis of socio-economic status on cholesterol lowering interventions in chronic kidney disease, Morton R, National Health and Medical Research Council (NHMRC)/Early Career Fellowships
The cost-effectiveness of adjuvant whole brain radiotherapy for melanoma brain metastases: a trial-based and modeled economic evaluation, Morton R, King M, Fogarty G, Nowak A, Hong A, Cancer Australia/Priority Driven Collaborative Cancer Research Scheme

2011

Patient INformation about Options for Treatments (PINOT): A prospective observational cohort study, five year follow-up., Morton R, Kidney Health Australia/Project Grant

2005

Strengthen Cancer Care initiative - Infrastructure Support for Clinical Trials Program, Morton R, Thompson J, Cancer Australia/Support for Cancer Clinical Trials - Existing National Cooperative Oncology groups

Collaboration Group Publications

Smit, AK., Espinoza, D., Fenton, GL., Kirk, J., Innes, JS., McGovern, M., Limb, S., On Behalf Of The Managing Your Risk Study Group.,Turbitt, E., Cust, AE. (2022). Communicating Personal Melanoma Polygenic Risk Information: Participants’ Experiences of Genetic Counseling in a Community-Based Study. Journal of Personalized Medicine, 12(10), 1581. [More Information]

International grants:

Dunhill Medical Trust (UK). “Advance care planning with older patients who have end-stage kidney disease: Feasibility of a deferred entry randomised controlled trial incorporating a mixed methods process evaluation.” CIs O’Halloran P, Brazil K, Noble H, Fogarty D, Murtagh F, Brown J, Shields J, Morton RL.

European Centre for Disease Control, European Union (EU). “Effectiveness and cost-effectiveness of screening migrants in Europe.” Pottie K, Vandvik P, Morton RL.

New Zealand Heart Foundation. “Canadian-Australasian Randomised trialof Screening Kidney transplant recipients for coronary artery disease (CARSK study).” Pilmore H, Chadban S, Cross N, Morton RL.

Other national grants:

Australian Government – Department of Health. National Palliative Care Projects.“Supporting provision of palliative care and advance care planning in general practice: a toolkit and training package targeting practice nurses.” Clayton J, Tieman J, Sylvester W, Halcomb E, Mitchell G, Phillips J, Shaw T, Morton RL.

Faculty of Medicine and Health

Page not found